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Abstract 
The purpose of this study was to investigate immunomodulating effects of environmental 
toxicants on cytokine and ROS production in white blood cells. Immunomodulating effects 
can either be investigated on a healthy immune system or on an immune system during the 
challenge of infection. To simulate infection two bacterial analogs, LPS and Pam3CSK4, and 
the bacteria Y.enterocolitica were used.  
Y.enterocolitica was used as a test candidate for the development of a whole blood model for 
characterization of bacteria. A concentration-dependent increase in Tnf-α production was 
observed after exposure to Y.enterocolitica. PBS should be used as a solvent for the bacteria, 
because cytokine production was induced by the growth medium (BHI). The volume of PBS 
(100µL-1mL) did not seem to affect the relative Tnf-α production pr. CFU in whole blood. 
The Tnf-α production in whole blood was also tested after exposure to the environmental 
toxicants A1242, A1254, Bisphenol A, HBCD, PCB77, PCB153, TBBPA and Triclosan. The 
first screening showed small but significant differences between the controls and all the 
toxicants tested. Different concentrations of A1254, HBCD and PCB77 were investigated 
further; no trends were observed. Priming with the bacterial analogs LPS (1ng/mL) and 
Pam3CSK4 (100ng/mL) showed no immunomodulations. 
Induction of ROS-formation in human neutrophil granulocytes by exposure to A1254, 
Bisphenol A, HBCD, PCB153 and Triclosan were investigated with a luminol 
chemiluminescence assay. All of the toxicants, except Bisphenol A induced a concentration-
dependent increase in ROS formation. Bisphenol A induced a reduction of the basal DMSO 
level of ROS. Immunomodulations of some of these responses were investigated with LPS 
priming or coexposure with 250 000 CFU Y.enterocolitica. The LPS priming seemed to 
suppress the normal response to the toxicants. Y.enterocolitica coexposed with PCB153 and 
Triclosan suppressed the effect of the single toxicants at higher concentrations, while A1254 
and PMA seemed unaffected. Binary mixtures of Triclosan, HBCD or Bisphenol A with PMA 
or PCBs were also investigated and compared to predicted values by the Loewe or the Bliss 
model. Only mixtures between Triclosan and A1254 or HBCD were significantly different 
from DMSO. PCBs mixed with HBCD seemed to follow concentration addition, and the 
mixture with HBCD and Triclosan followed independent action more closely. The models 
predicted the combinatory effect of all the other mixtures poorly. 
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1 Introduction  
1.1 Background 
The air we breathe and the food we eat contain compounds that humans are not aware of, such 
as dust, pathogens, environmental toxicants and pollutants. Pathogens are microorganisms 
which cause disease; examples are bacteria (food poisoning, plague, meningitis), fungi 
(allergic reactions, pneumonia) and viruses (the common cold, diarrhea, chicken pox) 
(Parham, 2009c). The environmental pollutants that humans are exposed to might contribute 
to the development of illnesses such as cancer (Kriek et al., 1998), chronic obstructive 
pulmonary disease (COPD)(Cazzola et al., 2007) and asthma (D'Amato et al., 2005).  
Bacteria, algae and spores that are present in soil or water can be transported by wind in drops 
of water, or on top of particles of dust or soil. Aerial dispersal is vital for many microbes in 
order to colonize new sites or as a part of their reproduction. Some fungi actively disperse 
spores in the air (Kuske, 2006). A number of these microbes may be pathogenic, as 
exemplified by the outbreaks of meningitis during the height of the winter dust winds in some 
West African regions (Sultan et al., 2005). 
The types of bacteria in the air are as diverse as in soil or water (Radosevich et al., 2002; 
Maron et al., 2005). Bacteria are mainly divided into two groups, gram-positive and gram-
negative. Gram-positive bacteria are stained purple by gram stain, while gram-negative 
bacteria remain unstained because they have an outer membrane with complex 
macromolecules such as lipopolysaccharide (LPS) and lipoprotein (Lawrence, 2000; Parham, 
2009c). The outer membrane of gram-negative bacteria help them survive the host’s defenses 
and make them more resistant to antibiotics (Campbell and Reece, 2005b). With DNA 
fingerprinting, Maron et al. (2005) found that 60% percent of an airborne bacterial 
community in rural France was gram-negative and 23% was gram-positive. Another study, by 
Radosevich et al. (2002) found that 50% percent of a sample from Utah were gram-positive.  
Other contaminants of air are environmental toxicants. They may be organic chemicals, such 
as brominated flame retardants (BFR) and polychlorinated biphenyls (PCB), or inorganic 
chemicals such as mercury and lead. They are often bio-accumulative, persistent and may 
adversely affect ecosystems. These toxicants can spread from products into water, air and soil 
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due to chemical processes, accidents at production facilities and during transport or waste 
handling. Persistent chemicals may bioaccumulate through the food chain and reach harmful 
concentrations for wildlife and for people eating contaminated food. Studies have shown that 
environmental contaminants can affect the reproductive system, the nervous system, cause 
cancer and be mutagenic (KLIF, 2011a). There are also concerns that they might affect the 
immune system (Klaassen and Watkins, 2003b). 
One cannot live without air and since it is a medium of transport for both environmental 
toxicants and bacteria, it is important to know how these contaminants affect the immune 
system. However, a problem, often encountered when studying immune effects of 
environmental toxicants, is relevant endpoints. The immune system is complex and comprised 
of several different organs and cells. Suppressed or activated effects are easy to spot if we are 
looking at the right endpoints, but what if some effects are averted from one type of immune 
effect to another (from inflammation to an allergic reaction)? Because of this, Holmstrup et al. 
(2010) define immunotoxicity as “any modulation (activation, suppression or deviation) of 
immune responses by chemicals that cannot be related to the infection with a certain type of 
pathogen”.  
1.2 Innate Immune Response in Whole Blood 
Whole blood contains plasma and cells (Fig. 1). Plasma is made up of 90% water, ions, 
proteins and substances transported by the blood (nutrients, waste products, hormones). The 
cells are platelets, erythrocytes (red blood cells) or leukocytes (white blood cells). Leukocytes 
can be subdivided into basophils, eosinophils, lymphocytes, neutrophils and monocytes. Their 
function in blood is for defense and immunity (Campbell and Reece, 2005a).  
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Figure 1 Constituents of Whole Blood (modified from (NetResourcesInternational, 2011)) 
The immune system is divided into the adaptive- and the innate immune system. The main 
component of the adaptive immune response is lymphocytes. They are divided into T-
lymphocytes, which cause cell-mediated immunity, and B-Lymphocytes, which cause 
antibody-mediated immunity (Parham, 2009d). The adaptive immune response increases 
effectiveness towards a bacterial infection after the first infection. 
The innate immune system has external and internal factors, and it acts at the onset of 
infection, with equal vigilance every time. The external factors are barriers that prevent 
pathogens from crossing the epithelia and colonizing tissues, such as skin and mucosal 
surfaces, and the enzymes and acidity of the gastrointestinal tracts. The internal factors 
consist of cells such as granulocytes and monocytes and the complement system (Parham, 
2009d).  
There are three types of granulocytes: eosinophils, basophils and neutrophils. Eosinophils 
produce chemicals that kill parasitic worms. Basophils release histamine and heparin. The 
cells are both involved in allergic manifestations (Sherwood, 2001). Neutrophils are the most 
abundant granulocytes and their effect will be described in section 1.2.2 below. 
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Monocytes circulate the blood for approximately three days before differentiating to 
macrophages or dendritic cells in lymphoid tissue. During an infection they respond to 
inflammation signals in the blood and move to the site of infection to mature. Macrophages 
are large phagocytes which ingest dead cells, bacteria or foreign materials and store it in 
vacuoles before disposal. Dendritic cells have similar functions, but they also act as cellular 
messengers that activate the adaptive immune response at the onset of an infection (Parham, 
2009d).  
1.2.1 Toll-like Receptors 
Toll-like Receptors (TLRs) help the innate immune system to recognize pathogens such as 
bacteria, fungi and viruses. TLRs are mainly expressed on dendritic cells and macrophages 
and control activation of these antigen-presenting cells (Parham, 2009b). Monocytes and 
Neutrophils also express some TLRs (Wang et al., 2000). There are 10 TLRs in the human 
genome. These receptors recognize conserved features of microbes called pathogen associated 
molecular patterns (PAMPs). Each TLR recognizes several different PAMPs (Parham, 
2009b).  
Activated TLRs induce formation of several cytokines. One example is tumor-necrosis-factor 
alpha (Tnf-α) (Parham, 2009b). Tnf-α is not usually detectable in healthy individuals, but 
elevated serum and tissue levels are found during inflammatory and infectious conditions 
(Nurnberger et al., 1995; Robak et al., 1998). Another cytokine synthesized at the onset of 
infection is interleukin-1 beta (Il-1β), which activates lymphocytes. Both Tnf- α and IL-1β are 
pyrogenic, which means that they cause fever (Parham, 2009b). It is mainly monocytes that 
produce cytokines in whole blood (Wang et al., 2000). 
The cytokine cascades for viruses and gram-negative 
and -positive bacteria are similar, even though they 
are initiated by different TLRs (Parham, 2009b). 
LPS is an endotoxin, with a polysaccharide region (o-
antigen) that varies somewhat in different gram-
negative bacteria, but they have a similar structure 
and they are all pyrogenic (Fig. 2). LipidA is the most 
conserved part of LPS. This region often activates 
Figure 2 Lipopolysaccharide modified from 
((Spectral Diagnostic Incorporated, 2006)) 
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TLR4, though some lipid A structures activate TLR2 instead (Bainbridge and Darveau, 2001; 
Pridmore et al., 2001; Werts et al., 2001).  
All TLRs except TLR3 activates the MyD88 dependent pathway (Fig.3) which cause 
inflammatory cytokine production. TLR4 and TLR3 activate the MyD88 independent 
pathway  which causes production of interferons 
(Fig. 3) (Kumar et al., 2009). 
In the Myd88 dependent pathway, LPS-binding-
Protein (LBP) binds to LPS in the blood. LBP 
delivers LPS to CD14 on the cell membrane. 
CD14 interacts with MD2-TLR4, which has a 
Toll/Interleukin-1 receptor (TIR) domain in the 
cytoplasm. TIR recruits MyD88, which 
phosphorylates interleukin-1 receptor-associated 
kinase 4 (IRAK4). Then TNF receptor associated 
factor (TRAF) 6 is phosphorylated and a kinase 
cascade begins. The cascade ends with 
phosphorylation of IκB kinase (IKK) (Schumann 
et al., 1990; Wright et al., 1990; Chow et al., 
1999; Hoshino et al., 1999; Yang et al., 1999; 
Anderson, 2000; Beutler, 2000; Parham, 2009b).  
Nuclear transcription factor κB (NFκB) is bound 
by its inhibitor IκB which prevents it from entering the nucleus. IKK phosphorylates IκB and 
this induces the release of NFκB from the complex. NFκB activates genes encoding 
inflammatory cytokines like Tnf-α and Il-1β (Parham, 2009b). 
Alternatively MD2 recruits TIR-domain-containing adapter-inducing interferon-β TRIF, 
which in turn recruits TRIF-related adaptor molecule TRAM. TRAF 3 is then phosphorylated 
and a kinase cascade is started. The cascade ends with interferon regulatory factor (IRF)3 
phosphorylation. IRF3 enters the nucleus and activates genes encoding type I interferons 
(IFN-α and IFN-β) (Parham, 2009b).  
The cytokine cascade activated by TLRs is both pro- and anti-inflammatory. An inflammatory 
response is beneficial at first, because it helps to clear the infectious agent. Prolonged 
Figure 3 Figure 4TLR4 signaling by the TRIF and 
MyD88 pathways modified from Parham (2009a). 
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inflammation is harmful because it may cause host toxicity and tissue damage (Zeytun et al., 
2010). An example is if a local infection becomes systemic, which causes the macrophages in 
the liver and spleen to start to secrete Tnf-α into the blood stream. If this goes unchecked it 
can cause organ failure and death. This is known as septic shock (Parham, 2009c). In other 
cases an inappropriate immune response may give rise to a prolonged and damaging 
inflammatory response like the chronic inflammatory disease rheumatoid arthritis, which 
causes severe pain in joints. Rheumatoid arthritis has been successfully treated with Tnf-
blocking agents, which indicates that Tnf-α is involved in the inflammation process (Bradley, 
2008). 
In studies of septic shock in vitro a whole blood model is often used with LPS as the 
instigator of the cytokine cascades. This model cannot be directly transferred to in vivo 
reactions because tissue macrophages also contribute greatly to the reaction in humans 
(Dorresteijn et al., 2010), but it is still useful for investigation of monocyte cytokine 
production. It is more cost efficient than isolating monocytes during the experiments, it gives 
the monocytes a more relevant environment, and pre-activation during monocyte isolation is 
avoided. Neutrophils may also produce cytokines, but their capacity for production is much 
lower than the monocytes’ (Damsgaard et al., 2009). Many white blood cells of the innate 
immune system have TLRs which are activated by PAMPs (Wang et al., 2000; Parham, 
2009b). The whole blood model can, with detection of cytokines or interferons, give an 
indication of immunomodulations after exposure to environmental toxicants or a mixture of 
environmental toxicants and known PAMPs. 
1.2.2 Neutrophil Granulocytes 
Of the granulocytes, neutrophils are the most abundant and the first line of defense after a 
bacterial invasion. They circulate the blood and migrate through tissue. Depending on their 
actions they can live from seven hours to two days (Quinn and Gauss, 2004). They are 
attracted to the cytokines and chemokines produced in response to TLR activation (Knapp, 
2010). When entering a contaminated site they engulf invading microorganisms into a 
phagosome and produce several cytotoxic agents to kill the organism (Hampton et al., 1998). 
During the phagocytosis of the intruding organism the neutrophil induces production of 
reactive oxygen species (ROS) and reactive nitrogen species (RNS) in a process called 
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respiratory burst (Freitas et al., 2009). This is harmful for the invading pathogens, but 
overproduction of ROS/RNS can also be harmful to the host (Conner and Grisham, 1996). 
Examples of reactive oxygen species are hydrogen peroxide (H2O2), superoxide anion (O2
•-
), 
hypochlorite (OCl
-
) and the hydroxy radical (OH
•
). The superoxide anion (O2
•-
) is formed in 
many auto-oxidation reactions and by the electron transport chain. Superoxide anion is 
transformed to hydrogen peroxide (H2O2) by the enzyme superoxide dismutase (SOD). The 
Fenton reaction creates OH
•
 from a reaction between H2O2 and Fe(II). OH
•
 reacts with 
virtually all biomolecules and is perhaps the most harmful oxygen radical. 
Reactive oxygen species are potentially toxic to the cells. They can initiate or enhance an 
inflammation response by upregulation of genes; for example, NF-κB (Conner and Grisham, 
1996). They can react with lipids, proteins, nucleic acids and other molecules and affect these 
molecules’ normal structure or function. Initiation of free radical-induced lipid peroxidation 
can result in chain reactions leading to the destruction of the cellular membrane (Myhre, 
2001). They have been linked to neurodegenerative disorders like Parkinson’s, Huntington’s 
and Alzheimer’s (Fonnum, 1998). Since ROS/RNS are physiologically useful in small 
amounts there are no systems in the cells that remove them completely (Barja, 1993). They, 
can for example, function as mediators of signals between membrane receptors and target 
proteins. An oxidative attack on a protein induces either a loss of function, a gain of function, 
or a switch to a different function (Droge, 2002). 
 
The respiratory burst in neutrophils is caused by the NADPH oxidase system, which is 
activated by a phosphorylation cascade. The NADPH oxidase system is a membrane bound 
enzyme with several protein subunits that catalyzes the production of superoxide radical from 
oxygen (Henderson and Chappel, 1996; Hampton et al., 1998; Babior, 2000; Babior, 2002; 
Quinn and Gauss, 2004; Freitas et al., 2009). The superoxide radical is relatively non-reactive 
in the cell, but rapidly changes to H2O2 at low pH or by superoxide dismutase (SOD) 
(Hampton et al., 1998). In neutrophils most of the H2O2 produced by NADPH is used by 
myeloperoxidase (MPO) to form HOCl, which is a potent bactericidal oxidant (Hampton et 
al., 1998).  
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1.2.3 Methods for Detection of Cytokines and ROS 
Cytokines and ROS production can be induced by chemicals as well as by pathogens. This 
means that the adaptive immune response might be stimulated from several sources at the 
same time and the actual response to pathogens might be upregulated, suppressed or diverted 
to another reaction (Holmstrup et al., 2010). Because of this, it is important to investigate how 
environmental toxicants affect cytokine and ROS production. Several methods have been 
developed that can be used to detect cytokines and ROS. 
ELISA -Enzyme Linked Immunosorbent Assay 
The ELISA is a specific and highly sensitive method for quantitative detection of cytokines or 
other chemicals in solution. A specific antibody is coated on a microtiter plate and the 
cytokine of interest will attach itself to the antibody. Then a second antibody, used for 
detection, binds on a different epitope on the cytokine. The detection antibody is labeled with 
biotin, which allows subsequent binding of a Streptavidin-conjugated enzyme. Any unbound 
reagents are washed away. Finally a substrate is added, causing a color reaction to develop 
that is proportional to the amount of cytokine bound. The concentration of cytokine is 
determined by comparison with a standard curve with known concentrations of cytokine. The 
detection limits for cytokine ELISAs are commonly in the lower picogram/ml range (Mabtech 
AB, 2011). 
Probes for Detection of Reactive Oxygen Species 
Formation of reactive oxygen species can in principle be measured in several ways in vitro. 
Among these are fluorometric probes (HE, Amplex red, DCFH etc.), colorometric probes 
(TMB, Cytochrome C) and chemiluminometric probes (Luminol, Lucigenin). Several of these 
have limitations such as low sensitivity and selectivity (Cytochrome C), underestimation of 
ROS production (HE) and dependence on HRP activity may occur (Amplex red, DCFH). 
(Freitas et al., 2009). Lucigenin, which only measures extracellular O2
•-
 (Kopprasch et al., 
2003; Pavelkova and Kubala, 2004) is highly specific (Freitas et al., 2009), but since it only 
measures O2
•-
 it should be used together with other probes to get a complete picture of ROS 
production. 
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The luminol probe, used in this study, was introduced in 1976 by Allen and Loos. Luminol 
reacts with ROS to produce an excited aminophtalate anion that emits light when returning to 
ground state (Briheim et al., 1984; Albrecht and Jungi, 1993; Lundqvist and Dahlgren, 1996; 
Faldt et al., 1999). Caldefie-Chèzet et al. (2002) concluded that Luminol only detects 
intracellular ROS production in an experiment where they compare different probes. This is 
not the overall agreement, as presented in the review by Freitas et al. in 2009. Luminol detects 
several ROS (O2
•-
, H2O2, HO
•
, HOCl) and RNS (
•
NO, ONOO
-
) both inside and outside of the 
cell. It is dependent on myeloperoxidase (MPO) and regarded as sensitive (Freitas et al., 
2009).  
1.3 Environmental Toxicants  
1.3.1 Brominated Flame Retardants 
Brominated flame retardants (BFRs) are chemicals used to prevent fires in materials. They 
interrupt the free radical chain created in the gas phase of the combustion process, thereby 
preventing or delaying the onset of ignition and slowing the rate of burning after ignition 
(Morose, 2006). They can be additives in the materials, in which case they can leak directly 
into the environment, or they can be chemically bound to the materials, in which case they 
can leak when the material deteriorates or in cases where there are leftovers that do not react 
in the production process. They can be found in domestic products like electronic equipment, 
upholstered furniture, interior textiles, automobile interior textiles, house walls, cellars and 
roofs (de Wit, 2002). Production of brominated flame retardants was approximately 300,000 
tons in 2001 (Morose, 2006). Some of these BFRs have been detected in environmental 
samples (de Wit, 2002).  
Hexabromocyclododecan (HBCD) 
HBCD, a brominated aliphatic cyclic hydrocarbon, is used as a an additive flame retardant in 
plastics, textiles and insulation (de Wit, 2002). Annual production of HBCD is approximately 
23,000 tons (Persistent Organic Pollutants Review Committee, 2011).  It is bioaccumulative 
and the concentration of HBCD increases along the food chain (Law et al., 2006). Humans are 
exposed mainly through diet, especially fish (Thomsen et al., 2008; Schecter et al., 2010), but 
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also through inhalation of dust particles (Thomsen et al., 2007; Roosens et al., 2009) and 
dermal contact with materials treated with HBCD (Thomsen et al., 2007).  
HBCD has been shown in laboratory animals to be a hepatic enzyme inducer (Hamers et al., 
2006), a developmental neurotoxicant (Eriksson et al., 2006), and an endocrine disruptor (van 
der Ven et al., 2006). HBCD also has an effect on dopamine and glutamate uptake in rat brain 
synaptosomes (Mariussen and Fonnum, 2003). 
In vitro HBCD affects natural killer cells’ lytic function and ATP levels at 10μM. Even a 
short exposure for one hour caused a progressive loss of lytic function over a six-day period, 
indicating an immunotoxic potential. This could affect a virus infection, since natural killer 
cells are important in recognizing and destroying virus infected cells (Hinkson and Whalen, 
2009). 
 
Figure 5 HBCD 
Tetrabromobisphenol A (TBBPA) 
TBBPA is a brominated flame retardant and is mainly used in epoxy resins of printed circuit 
boards and in other industrial materials (de Wit, 2002). TBBPA is used in large quantities 
with an annual production of approximately 200,000 tons (Morose, 2006). It chemically binds 
to the plastics and is not as easily released into the environment as other BFRs like HBCD. 
TBBPA is found in people exposed to TBBPA at work (Thomsen et al., 2001) and even in 
individuals with no direct occupational exposure (Thomsen et al., 2002; Hayama et al., 2004).  
Acute oral toxicity is low in laboratory animals (Darnerud, 2003). The lowest dose known to 
cause toxicity is 200mg/kg bodyweight causing nephrotoxicity in newborn rats (Kitamura et 
al., 2002; Fukuda et al., 2004). TBBPA is shown to affect dopamine and glutamate uptake in 
rat brain synaptosomes, cause ROS formation, induce cell death, calcium influx and elevation 
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of extracellular glutamate in rat cerebellar granule cells in vitro (Mariussen and Fonnum, 
2003; Reistad et al., 2007). TBBPA has a molecular structure similar to that of the thyroid 
hormone thyroxine (de Wit, 2002). This leads to concerns that TBBPA may interfere with the 
thyroid hormone system (Meerts et al., 2000; Kitamura et al., 2002). 
Watanabe et al. (2010) found that TBBPA has an effect on the immune response to 
respiratory syncytial virus infection in mice. Pullen et al. (2003) found that TBBPA may act 
as an immunotoxic compound by specifically inhibiting the expression of CD25. These 
experiments were done on splenocytes from mice. Reistad et al. (2005) found that TBBPA 
caused ROS formation in human granulocytes by activating respiratory burst through 
NADPH oxidase. 
 
Figure 6 Tetrabromobisphenol A 
 
1.3.2 Polychlorinated Biphenyls 
PCBs were introduced in 1929 in applications like cooling material in transformers and other 
electrical devices, hydraulic fluids and additives in different types of paint and glue (KLIF, 
2011b). Until 1984 about 1.2 million tons of PCBs had been produced worldwide and 20-30% 
of this has been released into the environment through burning, evaporation, leaks and 
dumping (Tanabe, 1988). Due to their high lipophilicity and structural stability, PCBs are 
persistent environmental pollutants and accumulate in higher trophic levels throughout the 
food chain (Tanabe, 1988; Fischer et al., 1998). In 1980, Norway followed other industrial 
countries and prohibited new use of PCBs (KLIF, 2011b). PCBs are still found in human or 
animal tissue throughout the world (Colborn et al., 1993; Kvalem et al., 2009).  
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Figure 7 General PCB structure 
The PCBs are a family of halogenated aromatic hydrocarbons with 209 possible congeners 
(Fig. 5). They are often divided into three different groups; the coplanar with no chlorine 
substitution in the ortho position; the non-coplanar with two or more ortho substitutions; and 
the mono ortho substituted PCBs, which may have a coplanar configuration some of the time. 
Coplanar PCBs can bind to the aryl hydrocarbon receptor (Ah-receptor). They mimic the 
toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD), which also binds to the Ah-
receptor (Safe, 1994). 
There are epidemiological studies of humans which show that PCBs may have an effect on 
neurological development and learning abilities (Tilson et al., 1990; Seegal, 1996; Tilson and 
Kodavanti, 1998; Canzoniero et al., 2006). These studies also indicate that PCBs cause skin-
disorders (Meigs et al., 1954; Swanson et al., 1995), cancer (Sinks et al., 1992; Swanson et 
al., 1995) and reproductive and developmental abnormalities (Taylor et al., 1989; Swanson et 
al., 1995). Studies done with Aroclors, which are commercial PCB mixtures, showed that 
PCBs cause reproductive disorders on rabbit embryos (Seiler et al., 1994). Studies on other 
animals with Aroclors have shown that they can be estrogenic, thyrotoxic, liver enzyme 
inducers and immune suppressing (Harris et al., 1993; Cooke et al., 1996; Omara et al., 1997). 
The general opinion seems to be that ortho-substituted PCBs are primarily the cause of the 
neurotoxic effects observed in Aroclor mixtures (Seegal et al., 1990; Seegal et al., 1991a; 
Seegal et al., 1991b; Shain et al., 1991; Mariussen et al., 2002; Mariussen and Fonnum, 
2006). 
Ortho-chlorinated PCBs are known to activate neutrophils. Ganey et al. (1993) exposed 
human and rat neutrophils to the PCB mixture Aroclor 1242. The neutrophils induced 
formation of O2
-•
 and secreted lysosomal products. Studies with single PCB-congeners have 
shown that the effect is attributed to the non-coplanar ortho-chlorinated PCBs (Ganey et al., 
1993; Brown and Ganey, 1995; Tithof et al., 1995; Voie et al., 1998).  
13 
 
There are three pathways that have been shown to be necessary for activation of neutrophils 
by PCBs; release of intracellular Ca
2+
(Brown and Ganey, 1995; Voie and Fonnum, 1998), 
possibly by activation of phospholipase C and/or D (Voie et al., 1998); tyrosine kinase 
activation (Tithof et al., 1997); and arachidonic acid released by activation of phospholipase 
A2, which in turn activates the NADPH oxidase system (Henderson et al., 1993; Dana et al., 
1994; Tithof et al., 1996; Fischer et al., 1998).  
PCB 77, a coplanar PCB, has shown a potential to induce the expression of proinflammatory 
cytokines, including IL-6 and Tnf-α in vitro with human umbilical vascular endothelial cells 
(HUVEC). PCB was also observed to alter insulin-activated signaling by Tnf-α secretion 
(Wang et al., 2010).                            
 
Figure 8 PCB77                                      Figure 9 PCB153 
1.3.3 Bisphenol A  
Bisphenol A is a monomer used in production of polycarbonate plastics used in food and 
beverage packing. Bisphenol A is also used to make resins that line beverage cans (Talsness 
et al., 2009) and in dental composites (ACC, 2011). In 2002, approximately 2.8 million tons 
of Bisphenol A was produced globally (ACC, 2011). Bisphenol A is listed as an endocrine 
disruptor (Feldman, 1997; Sonnenschein and Soto, 1998). It shows estrogenic effect at high 
doses. Estrogens are often immunomodulating as well as reproductive agents (Kittas and 
Henry, 1980; Luster et al., 1984). As a result of several animal studies, concerns have been 
raised that Bisphenol A may affect the nervous, reproductive  and  immune systems both as a 
developmental toxicant and when exposed as adult (Richter et al., 2007).  
Bisphenol A has been reported to modulate immune function at doses between 2.5 and 30 
μg/(kg day), including patterns of cytokine and antibody production, response to infection and 
autoimmune disease progression in mice (Sawai et al., 2003; Yoshino et al., 2003). It has also 
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been shown that Bisphenol A exposure is associated with modulation of innate immune 
system cell function (Sugita-Konishi et al., 2003). Yoshino et.al (2004) reported that prenatal 
exposure to Bisphenol A up-regulates immune responses, including T-lymphocyte responses, 
in mice. Reistad et al. (2005) found a small dose-response dependent increase in ROS 
formation with a DCFH-DA probe on human granulocytes, but not with a lucigenin probe, 
indicating that the ROS formation was intracellular. 
 
Figure 10 Bisphenol A 
1.3.4 Triclosan 
Triclosan adversely affects most gram-negative and gram-positive bacteria. It is used in 
personal care products like toothpaste, cosmetics, household items, medical devices, and in 
clinical settings where its antimicrobial activity is necessary (Jones et al., 2000). In Europe, 
450 ton Triclosan were used in 2006 (SCCS, 2009). It is likely that many humans are exposed 
to Triclosan throughout their entire lifetime. It has been detected in the environment and even 
in human plasma at concentrations of 0.1-8.1 ng/mL. Individuals who used products 
containing Triclosan had elevated levels of Triclosan in their body fluids (milk and plasma) 
(Hovander et al., 2002; Sandborgh-Englund et al., 2006). 
Triclosan disrupts membrane activity in bacterial cell membrane without causing leakage of 
intracellular components (Villalain et al., 2001; Guillen et al., 2004). Triclosan is also an 
inhibitor of the enoyl-reductase of type II fatty acid synthase involved in the bacterial lipid 
biosynthesis (Levy et al., 1999; Stewart et al., 1999; Ward et al., 1999; Heath et al., 2000). 
Triclosan possesses intrinsic estrogenic and androgenic activity (Gee et al., 2008). There have 
been studies to check for reproductive toxicity, genotoxicity, carcinogenicity or chronic 
toxicity, but nothing significant has been reported (Fang et al., 2010). In an ex vivo whole 
blood model, Triclosan (0.5µg/mL) has shown broad anti-inflammatory activity by 
suppression of Tnf-α production (Barros et al., 2010). 
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Figure 11 Triclosan 
1.4 Mixture Effect Models 
Environmental toxicants usually appear in mixtures. Little is known about combinatorial 
toxicity of environmental pollutants, and the fact that these pollutants may have additive or 
synergistic effects is therefore of great concern. 
There are two accepted models for the study of mixture effects - independent action and 
concentration addition. Independent action is common in research on multiple drug-exposure 
(Berenbaum, 1985) and in risk management recommendations (Altenburger et al., 2000). 
Concentration addition is often used in aquatic toxicology and is said to be well suited for the 
prediction of nonspecifically acting compounds like organic non-reactive chemicals 
(Konemann, 1980; Konemann, 1981; Hermens et al., 1984). 
Bliss (Independent action) 
This model was proposed by Bliss in 1939, and assumes that each chemical has a different  
mode of action. This model is based on probability and claims that the effect of two 
compounds in a mixture is equal to the sum of the effect of each of the compounds minus the 
product of the effects of each compound. Effects (E) are defined as fractions of maximum 
effect. 
E(x,y) = E(x) + E(y) – (E(x)*E(y))         (1) 
Independent action often gives a good prediction of the effect of different compounds in 
mixtures as long as they all are above their no observed effect level (NOEC) and reacts 
independently. The model will, however, often underestimate a mixture effect if the 
compounds are under the NOEC and reacts similar to concentration addition as described 
below (Rajapakse et al., 2002). 
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Loewe (Concentration addition) 
This model was proposed by Loewe and Muischnek in 1926, and assumes that each chemical 
has the same mode of action towards a cellular target, but might have different potencies. 
Chemicals in a mixture at concentrations below NOEC will be able to add to the effect of the 
mixture. As long as the equation (2) holds for an effect X, the concentration addition holds. If 
the sum is higher than one, there might be some sort of antagonistic relationship, and if the 
sum is lower there might be a synergistic relationship (Berenbaum, 1985; Rajapakse et al., 
2001). 
da/ECa + db/ECb = 1 (Andersen et al., 2009)  
or more generally: Σ (ci/ECxi) = 1 (Berenbaum, 1985; Rajapakse et al., 2001)   (2) 
da= concentration of substance a that together with substance b exerts a given effect = ECmix*pa 
ECa = the dose necessary for substance a to give the same effect as substance a and b together (ECmix). 
pa = the ratio concentration of substance a in the mixture. 
ECmix = the effective concentration of the mixture. 
ECmix*pa /ECa + ECmix*pb /ECb =1  ECmix = 1/ ((pa/ECa) + (pb/ECb))     (3) 
This equation which was developed from an article by Rajapakse (2001), was used to 
calculate the predicted effect of mixtures.  
1.5 Object of Investigation 
The purpose of this study is to look for modulations of the immune response. Environmental 
toxicants are suspected to have immunomodulating effects. Some have shown effects on 
cytokine production in vitro (PCB77 and Triclosan) (Barros et al., 2010; Wang et al., 2010); 
others like Bisphenol A (Reistad et al., 2005) and ortho-chlorinated PCBs (Voie et al., 1998) 
have shown effects on ROS formation in human neutrophil granulocytes. 
It is important to know how environmental pollutants affect a healthy immune system, but it 
is equally important to know how they interact with pathogens that cause disease. Will the 
immune response to infection be affected by environmental toxicants present? To be able to 
investigate this, it is, in addition, necessary to know how pathogens affect the immune 
response. It is also important to find out if the environmental toxicants interact, because they 
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often occur in the same environment. For risk assessment purposes it is therefore necessary to 
decide if they should be investigated separately or grouped according to their effects.  
The objects of investigation in this thesis are: 
- To develop a whole blood model to use on characterization of bacteria. 
- To investigate environmental toxicants’ effect on cytokine production of healthy cells 
and on cells fighting an infection in whole blood.  
- To investigate the effect of environmental toxicants on ROS production in human 
neutrophil granulocytes. 
- To investigate the immune modulating effects on ROS production in human 
neutrophil granulocytes when exposed to environmental toxicants and bacteria or a 
bacteria-analog. 
- To investigate the effects of binary mixtures of environmental toxicants on ROS 
production in human neutrophil granulocytes to test if the Loewe- or the Bliss model 
predicts the result. 
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2 Materials and Methods 
2.1 Chemicals 
Table 1 Chemicals used in these experiments. 
Chemicals Producers 
A1254 Accustandard Inc. (New Haven, USA) 
A1242 Accustandard Inc. (New Haven, USA) 
Agar Merck (Darmstadt, Germany) 
α-Cyano-4-hydroxycinnamic acid (CHCA) Bruker Daltonics (Germany) 
Brain Heart Infusion (BHI) Oxoid Ltd. (Basingstock, England) 
Bisphenol A Sigma-Aldrich Co. (Meriden, USA) 
9mL Vacuette with K3EDTA 
 
 
Greiner bio-one GmbH (Kremsmünseter. Austria) 
9mL Vacuette with LithiumHeparin Greiner bio-one GmbH (Kremsmünseter. Austria) 
CaCl2  Merck (Darmstadt, Germany) 
Dextran Pharmacia Fine Chemicals (Uppsala, Sweden) 
Dimethylsulfoksid (DMSO) Sigma-Aldrich Co. (Meriden, USA) 
Forward primer 933F16S Invitrogen Corporation (Camarillo, USA) 
d-Glucose Merck (Darmstadt, Germany) 
KCl Merck (Darmstadt, Germany) 
KH2PO4 Merck (Darmstadt, Germany) 
LPS Escherichia coli 0111:B4 Sigma-Aldrich (St.Louis, USA) 
Luminol Sigma-Aldrich (St.Louis, USA) 
Lymphoprep Axis-Shield PoC AS (Oslo, Norway) 
Heksabromcyclododekan (HBCD) Promochem GmbH (Germany) 
H2SO4 Merck (Darmstadt, Germany) 
MgCl2 Merck (Darmstadt, Germany) 
MgSO4 Merck (Darmstadt, Germany) 
NaCl Merck (Darmstadt, Germany) 
NaHCO3 Merck (Darmstadt, Germany) 
Na2HPO4 Merck (Darmstadt, Germany) 
NH4Cl Merck (Darmstadt, Germany) 
N-[2-hydroxyethyl] piperazine-N’-[ethansulphonic acid] 
(HEPES) 
Sigma-Aldrich (St.Louis, USA) 
PCB 153 Accustandard Inc. (New Haven, USA) 
PCB 77 Promochem GmbH (Germany) 
Phosphate Buffered Saline PBS Sigma-Aldrich (St.Louis, USA) 
Pam3CSK4 InvivoGen (San Diego, USA) 
Phorbol 12myristate-13-acetate (PMA) Sigma-Aldrich (St.Louis, USA) 
Reverse Primer  1387R16S  Invitrogen Corporation (Camarillo, USA) 
SYBR green mix I Roche Diagnostic (Germany) 
Tetrabromobisphenol A (TBBPA) Larodan Fine Chemicals AB (Malmö, Sweden) 
Triclosan Dr. Ehrenstorfer GmbH (Augsburg, Germany) 
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2.2 Whole Blood Experiments  
2.2.1 Preparation of Y.enterocolitica 
Y.enterocolitica (ATCC, Chicago, USA) is a gram-negative bacteria (Brubaker, 1991) and 
was used as an example for real-life infection when developing the whole blood model for 
bacteria. These bacteria were chosen because they have LPS similar to other gram-negative 
bacteria (Mandel et al., 2005), and were therefore expected to produce Tnf-α. They grow in 
temperatures ranging from 5 to 42 ºC (Brubaker, 1991). In our laboratory they grow on brain-
heart-infusion medium at 30ºC (ATCC, 2010). 
Y.enterocolitica was transferred from a stock solution (still frozen) by a small inoculation 
spatula and spread on a Brain Heart Infusion (BHI) agar plate. Then it was grown overnight at 
30ºC. To maintain fresh bacteria, a colony was re-inoculated every week. In cases of changed 
morphology (transparency, colour, size), a new inoculation from the stock solution was 
prepared as above. One colony of Y.enterocolitica was picked from a culture with fresh 
bacteria and transferred to 50mL BHI medium. The culture was rotated at 200 rpm and 
incubated overnight at 30ºC. Then the culture was diluted with medium to OD=0.1 (optical 
density at λ=600nm). OD was measured each following hour while the bacteria grew, still 
rotated at 200 rpm in 30ºC. At the same time points as OD was measured, dilutions (10-1–10-7) 
of the solution were made in PBS and plated out on BHI-agar, so that colony forming units 
(CFU) could be counted the next day. This was done with 3 parallels for each dilution at each 
time point. 
These experiments were done to calculate the growth rate of Y.enterocolitica in BHI. This 
was used in later experiments to calculate how much culture to use to get the amount of 
Y.enterocolitica needed for the experiments. Log(OD) versus log(CFU) is supposed to be a 
linear slope in the exponential growth phase of bacteria (Maddigan and Martinko, 2006a). 
With linear regression, formula 4 was used to predict the amount of bacteria in the culture 
(see appendix II.i).  
Log CFU=0.9111*Log(OD)+8.6042       (4) 
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Preparation of Bacteria Solution to the Whole Blood Experiment:  
One colony of Y.enterocolitica was picked from a culture with fresh bacteria and transferred 
to 50mL BHI-medium. The culture was rotated at 200 rpm and incubated overnight at 30ºC. 
The next morning the culture was diluted with BHI-medium to OD=0.1. Then it grew for 
about 3 hours until OD was approximately 0.6. Then three different amounts of 
Y.enterocolitica (10
6
, 10
7
, 10
8
) were mixed with different amounts of BHI (1, 0.5, 0.2, 0.1mL) 
and 1mL blood. This was done to investigate how the medium and different concentrations of 
bacteria affected cytokine production in whole blood. These experiments indicated that the 
medium could have a strong effect on the results. The experiment was repeated, but this time 
the bacteria was washed (*2) and dissolved in PBS. 
LPS were used as a gram-negative bacterial analog. LPS from E.coli can induce pro-
inflammatory responses like macrophage-, monocyte- and mast cell production of cytokines. 
These cytokines include; IL-1β, Tnf-α, IL-6, IFN-γ, IL-12, IL-13 and IL-8. (Morrison and 
Ryan, 1979; Kluger, 1991; Van Zee et al., 1991; Klir et al., 1993; Roth et al., 1993; Jansky et 
al., 1995; Wang et al., 2000; Supajatura et al., 2002; Madianos et al., 2005; Moller et al., 
2005; Andersson and Sundler, 2006).  
Pam3CSK4 was used as a gram-positive bacterial analog. It is a synthetic tripalmitoylated 
lipopeptid which functions like the acylated amino terminus of bacterial lipoproteins. 
Pam3CSK4 binds to a TLR2/TLR1-dimer and activates NF-κB (Aliprantis et al., 1999; 
Ozinsky et al., 2000). TLR2 is important in gram-positive bacteria recognition (Takeuchi et 
al., 1999).  
2.2.2 Preparation of Whole Blood 
The whole blood model is a useful tool to investigate induction of cytokines on a mixed white 
blood cell population. Studies have shown that the leukocyte counts in whole blood and the 
viability of the cells are very high, even after 24 hours without supply of oxygen. In the sealed 
plastic container, oxygen consumption decreases slowly over time, which indicates that 
metabolic activity goes down during the experiments (Wang et al., 2000). 
Blood from male volunteers age 23-55 was used in all experiments. The blood was 
heparinized in the vacuettes used to collect blood from the donors. Each donation of blood 
was between 40 and 100 mL. The cell count was measured for each individual donor at each 
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donation with an ADVIA60 hematology system. Whole blood (1-2mL) was divided into 
bottles and mixed with the bacteria solutions or environmental toxicants. The blood was 
slowly rotated at 37ºC for six or 24 hours.  
Plasma was removed from the whole blood by centrifugation in 15 minutes at 2000g. The 
plasma was frozen and stored for later analyses with ELISA according to the protocol 
provided by the manufacturer. We tested for known pyrogenic cytokines Tnf-α (Invitrogen 
Corporation, Camarillo, USA) and IL-1β (R&D systems Inc., Minneapolis, USA). The 
detection limit was 31.25pg/mL for Tnf-α and 7.8pg/mL for IL-1β. The reagents and 
antibodies used were from the manufacturers of the ELISA kits, except Coating Buffer A 
(Tnf-α) and stop solution (Il-1β) (see appendix I.ii). 
Identification of Bacteria 
Polymerase Chain Reaction (PCR) 
The PCR is an enzymatic amplification of a specific section of double stranded DNA using 
DNA polymerase.  A primer pair flanking the DNA fragment on the 3´ends specifies the 
amplification target sequence. DNA polymerase synthesizes a new DNA strand, in the 
5´direction, using the primed DNA. The PCR reaction consists of three cyclic steps: 
denaturation, annealing and extension (see table 3)(Sanger et al., 1977). After the cycles have 
been completed the sequence can be analyzed. If it has several variable parts (not conserved 
gene sequences) the copied DNA can be used to identify the bacteria the DNA came from 
(Maddigan and Martinko, 2006b) 
 
One colony from BHI-agar plate with Y.enterocolitica was diluted in 500µL dH2O and boiled 
at a 100ºC for 10 minutes, to destroy the membrane so that the DNA was accessible in the 
solution (DNA solution). A master mixture with primers and Cybergreen mix I was made and 
18µL were transferred to each well (table3). Then 2 µL of DNA solution was transferred into 
the appropriate wells. The primers used should give products with v6, v7 and v8, three 
variable parts of the conserved 16S gene. Afterwards the plate was sealed with a plastic strip 
and quick-spun. Then it was placed in the PCR machine (LightCycler 480, Roche Diagnostic, 
Germany) following the cycles described in table 3.  
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Table 2 The recipe used for PCR.  
Reagent Quantity in each well Master Mixture  
Enzyme mix (SYBR Green I*) 10 µL 100 
Forward primer 933F16S (5 µM) 4 µL 40 
Reverse Primer  1387R16S (5 µM) 4 µL 40 
DNA solution:  2 µL 0 
*consists of FastStart Taq DNA Polymerase, reaction buffer, cNTP mix (whit dUTP instead of dTTP), SYBR Green I 
dye, and MgCl . 
Table 3 PCR-program 
 
 
 
 
The double-stranded DNA is separated by high temperature (>90
o
C) during denaturation. The 
temperature is lowered to between 50-60
o
C for annealing between single DNA strand and 
primer. During the extension phase, a DNA polymerase synthesizes a new DNA strand using 
the primed DNA. Repeating the amplification steps cyclically results in a large amount of 
product in a short time (10 – 90 minutes). The PCR products were sent to Eurofin MWG 
Operon (Norway) for analysis of the PCR sequence. These sequences were then compared to 
sequences in the BLAST nucleotide database and the ribosome database project to confirm 
that this was the ATCC9610 strain of Y.enterocolitica. 
 
MALDI-TOF 
Matrix Assisted Laser Desorption Ionisation time-of-flight (MALDI-TOF) mass spectrometry 
can be used to determine whole bacteria taxonomy (Lay, 2001). It is also used for the analysis 
of proteins, peptides, glycoproteins, oligosaccharides, and oligonucleotides. MALDI is based 
on the bombardment of sample molecules with a laser light (337nm) to bring about sample 
ionisation. The sample is mixed with a highly absorbent matrix, which transforms the laser 
energy into excitation energy for the sample. This leads to sputtering of analyte and matrix 
ions from the surface of the mixture (Ashcroft, 2011) and this is measured by the computer. 
Each bacteria strain has a unique mass spectra fingerprint, because of differences in protein 
amount and types of proteins present. The bacteria taxonomy can be identified by comparison 
to archived spectra (Holland et al., 1996).  
Analysis Temperature Cycles Time 
Denaturation 95ºC 1 5 min 
PCR: 
Denaturation 
Annealing 
Extension 
 
95 ºC 
58 ºC 
72 ºC 
 
32 
32 
32 
 
10sec 
10sec 
20sec 
Final Extension 72 ºC 1 5 min 
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One colony from a BHI plate with Y.enterocolitica was transferred to a chip. 1-2µL matrix (α-
Cyano-4-hydroxycinnamic acid (CHCA)) was added on top of the Y.enterocolitica colony and 
then airdried before the chip was placed in the mass spectrometer (Bruker Daltonics, 
Germany). The mass-spectra achieved were compared to a database provided by Bruker 
Taxonomy (Bruker Daltonics, Germany). 
2.3 Isolation of Granulocytes 
Human venous blood (30-60mL) was obtained from healthy female volunteers (ages 23-50) in 
EDTA vacuettes. Neutrophil granulocytes were separated from EDTA blood by dextran 
sedimentation followed by a standard density gradient centrifugation as previously described 
by Bøyum (1991). 30 mL EDTA blood from individual donors was mixed with 3 mL 6% 
dextran (in 0.9% NaCl) and left for sedimentation at room temperature for 30 minutes. The 
supernantant containing granulocytes was subjected to Lymphoprep density gradient 
centrifugation at 690*g for 15 minutes. The pellet was washed in 10mL 0.9% NaCl and then 
resuspended in 5mL 0.83% NH4Cl for 7 minutes to lyse the erythrocytes, and then centrifuged 
for 7 minutes (690*g). This process was repeated until the pellet was white. The cells were 
resuspended in HEPES-buffered (20mM) HBSS (CaCl2 1.3 mM, KCl 5.4 mM, KH2PO4 0.44 
mM, MgCl2 0.49 mM, MgSO4 0.41 mM, NaCl 140 mM, NaHCO3 4.2 mM, Na2HPO4 2.7 
mM), pH 7.4  with 5 mM glucose. The number of granulocytes was determined with 
ADVIA60 hematology system. The cells were kept on ice (approximately 4ºC) until used 
(maximum 2 hours). 
2.3.1 Chemiluminescence Assay 
The luminol-amplified chemiluminescence was measured by the luminometer FLUOStar 
Optima (BMG LabTech, Germany). The reaction mixture (250µL) contained 0.1 mM 
Luminol, 2x10
5
 cells and increasing concentrations of the test compounds as seen in section 
I.iii in the appendix. Chemiluminescence was measured for approximately 60 minutes at 
35ºC. Each concentration was tested in triplicate and the experiments were repeated at least 
three times. The cells and reagents were prepared in HEPES-buffered (20mM) HBSS with 5 
mM glucose. A positive control with PMA (1*10
-8
M) was included in all experiments. This is 
a known Protein Kinase C (PKC) activator, and activates the NADPH oxidase system in 
granulocytes, which leads to ROS production (Benna et al., 1997; Hsu et al., 2008). 
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2.3.2 Calculation of Results 
The production of ROS in granulocytes exposed to bacteria and toxicants was compared with 
a DMSO-control. A DMSO effect was calculated based on all the experiments. The effect was 
90% ± 20% of luminol with HBSS only, which was not significant. 
The chemoluminescence produced in the experimental assays was given as the area under 
curve (AUC). AUC varied substantially between the experiments, even for the controls 
(HBSS and DMSO), which made it difficult to compare results. To compare all the 
experiments in a more convenient way, the results from each experiment were transformed to 
multiples of the control (DMSO). All the results are therefore presented as multiples of 
DMSO’s AUC. 
The mixtures of environmental toxicants were made at a ratio according to the EC50 ratio of 
the toxicants. EC50 was decided from the asymmetrical Hill-curve for each of the 
environmental toxicants (formula 5) with Graph Pad Prism (GraphPad Software, Inc., USA). 
These curves were also the basis for the Bliss and Loewe predictions of the mixtures.  
 
Formula 5 The asymmetrical Hill shape function. Min = minimal  observed effect; Max = maximal observed effect;      
c = concentration of test agent; EC50 = the concentration of test agent yielding half-maximal effects and p is the slope 
parameter (Rajapakse et al., 2002). 
2.3.3 The Bliss Model 
The Bliss independence model was calculated for all the mixtures. The Hill-shape curve 
function of each chemical in the mixture was used as a basis for the Bliss prediction. A 
standard deviation (SD) was calculated based on the individual Hill-shape curve from the 3-4 
experiments with each chemical in the mixture. This SD was transformed the same way as the 
Bliss predictions. This was done to show that individual variance strongly affected the 
predictions. 
For this model to work, the effect of each substance needs to be a number between zero and 
one. To manage this, all effects were divided by the maximum effect (the top of the Hill-
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shape curve) of the substance in the mixture with the highest effect. It was necessary to 
perform this transformation on the observed values as well, to be able to compare the values 
with the predictions. 
2.3.4 The Loewe Model 
The Loewe additivity model was calculated for mixtures with a positive Hill slope. Bisphenol 
A, which had a negative hill slope, clearly reacted in a different manner than the rest, and the 
Loewe additivity model was not applicable. The original approach from Loewe and 
Muischnek (1926) did not include a way to calculate the SD. To check if the eventual 
deviation from the model was due to chance or of actual relevance, a standard deviation was 
calculated based on the individual Hill-shape curve from the experiments with each chemical. 
To calculate the Loewe effect, formula (3), was used to calculate ECmix, which is the effective 
concentration of the mixture. Then the effect of the mix was found in a table with theoretical 
ECmix vs. effect. The theoretical ECmix is based on what dose of each of the components gives 
the same effect according to a Hill-shape curve calculated from experiments with the single 
compounds. The slope of the individual dose-response curves differs between the individual 
constituents of the mixtures, but according to  Berenbaum (1989) this model is independent of 
the shape of the individual dose-response curves. 
The Loewe model was used on effects between zero and one. To accomplish this, new hill-
shape curves were calculated. The maximum (from the hill-shape-formula) of the compound 
with the highest maximum in the binary mixture were used, and relative dose-response curves 
were calculated. If the overall highest result had been used, it would not have been possible to 
calculate Hill-shape curves for some of the compounds. 
2.4 Stock Solutions  
All stock solutions were dissolved in DMSO, except TBBPA which was dissolved in 
methanol, and LPS and Pam3CSK4 which were dissolved in 0.9% NaCl.  In all experiments 
the concentration of solvent never exceeded 0.5%, with one exception. 500µL stock solution 
with Y.enterocolitica was mixed with 9.5 mL human neutrophil granulocytes in HBSS, which 
caused a five percent dilution of the cell-solution. When mixing this with toxicants and 
luminol the total solution was diluted two percent with PBS. This was necessary to inhibit 
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growth in the stock solution of bacteria during the experiment, so that all the parallels got the 
exact same amount of bacteria. 
2.5 Statistics 
The data are given as mean±SD. Statistical analysis was performed with Graph Pad Prism. 
Data were considered significant at a level of P < 0.05. A Kolmogorov-Smirnov test indicated 
that the responses fit a Gaussian distribution. Analysis of variance (ANOVA) was used to 
calculate significance for all the dose-response curves and the Dunnet Multiple Comparison 
Test was used as a post-test to determine significances for each concentration compared to the 
control. A two-way ANOVA was used to calculate significance between treatments 
(LPS/bacteria/time) with different concentrations of toxicants or bacteria present. A 
Bonferroni post-test was used to indicate significances for each concentration compared to the 
control. A two way ANOVA investigates; if the dose has the same effect at all values of 
treatment (LPS, bacteria, time); if the dose affects the result; and if the treatment affect the 
result (Motulsky, 2003). Below all the figures where a two-way ANOVA has been used, a 
parenthesis with the result will be presented (interaction; dose; treatment;).  
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3 Results 
3.1 Whole Blood Model  
3.1.1 Whole Blood Experiments with Bacteria 
The viability of the bacteria in whole blood was tested by comparing growth in different 
ratios of PBS. CFU was counted at t=0 (Fig. 12), and after six and 24 hours, to see if the 
bacteria were still viable. The viability of the bacteria in blood varied between subjects (data 
not shown) which may cause variations in the results. As seen in figure 12, the actual amount 
of CFU calculated did not predict CFU closely (see appendix II.i). Because of these 
variations, later experiments with granulocytes were done with the same stock of bacteria 
during the same day and CFU was counted to confirm the bacteria amount used in the 
experiment.  
 
 
Figure 12 Comparison of counted CFU on BHI plates (t=0) with calculated CFU by formula (4) (n=3).  
BHI-medium caused some background in cytokine production (data not shown (n=4)). This 
problem was reduced by washing and dissolving the bacteria in PBS (Fig. 13). Increasing the 
amount of bacteria induced increased production of Tnf-α (Fig. 13). This response was 
somewhat suppressed after 24 hours, not significantly. The cytokine production after 
exposure to Y.enterocolitica varied more between subjects compared to the LPS response. 
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This is probably caused by the difference in amount of bacteria present. When we calculated 
Tnf-α production per CFU present it seemed that the amount of PBS had no influence on Tnf-
α production (Fig. 14).  
 
Figure 13 Tnf-α –production after exposure to different concentrations of Y.enterocolitica with different 
concentrations of PBS in 1mL whole blood for 6 and 24 hours. Two-way ANOVA with Bonferroni posttest indicated 
statistical significance between the controls and different concentrations of Y.enterocolitica. (interaction: ns, CFU: 
***, time: ns) ***p<0.001  **p<0.01 and  *p<0.05 (n=3)  
 
Figure 14 Tnf-α production pr. CFU. Two-way ANOVA indicated that only CFU accounts for the variance 
(interaction: ns, CFU: ***, PBS: ns) ***p<0.001 (n=3) 
The morphology of the bacteria changed over time and because of this it was necessary to 
confirm the bacteria species. This was done in approximately 50% of the experiments with 
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Y.enterocolitica, of which one colony was checked with PCR or MALDI-TOF. The results 
were always positive for the Y.enterocolitica serotype used in these experiments (see 
appendix II.ii).  
3.1.2 Whole Blood Experiments with Environmental Toxicants 
Whole blood was exposed to environmental toxicants for six and 24 hours to investigate 
induction of cytokine production. Eight different chemicals were screened at high 
concentrations. Apparently, all the test substances induced a small increase in Tnf-α 
production in some of the donors, but because of the huge variation between donors the 
results were not significant (Fig. 15). 
 
Figure 155 Tnf-α production in whole blood after exposure to different environmental toxicants at 50µM. 
PCB77 is at 10 µM. The positive control LPS are at 14000 pg/mL at 6 hours (data not shown). Two-way 
ANOVA indicated no statistical significance between the controls (DMSO/Methanol) and the 
environmental toxicants. (n=5) 
A dose-response relationship was then evaluated for three of the chemicals, namely PCB77, 
A1254 and HBCD. However, in these experiments there was no trend in formation of Tnf-α 
and no significant formation of IL-1β (Fig 16 -17). 
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Figure 16 Tnf-α production in whole blood after exposure to different environmental toxicants at different 
concentrations after 6 and 24 hours incubation. Two-way ANOVA with Bonferroni posttest indicated statistical 
significance between DMSO and the environmental toxicants, there were no relationship between 
increasing/decreasing dose and response making the result difficult to interpret.  (A1254: interaction: *, dose: *** , 
time:***; HBCD: interaction:***, dose:***, time:***; and PCB77: interaction:**, dose:***, time:***) ***p<0.001   
**p<0.01 and  *p<0.05 (n=5) 
 
Figure 17 IL1-β production in whole blood after exposure to different environmental toxicants at different 
concentrations after 6 and 24 hours incubation. Two-way ANOVA with Bonferroni posttest indicated no statistical 
significance. (n=3)  
A dose-response experiment with LPS and Pam3CSK4 was performed to determine which 
concentrations to be used when exposing whole blood to mixtures of bacterial analogs and 
environmental toxicants. We wanted a concentration in the middle of the linear slope, so that 
the environmental toxicants could show suppressing or activating effects on the expected 
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effect of the bacterial analogs. Both LPS and Pam3CSK4 induced a concentration dependent 
increase in Tnf-α production (Fig.18-19). In the mixture experiments, 1 ng/mL was chosen for 
LPS and 100ng/mL for Pam3CSK4. Time seemed to have a suppressing effect on the 
induction of Tnf-α by LPS and Pam3SCK4. Two chemicals, namely A1254 and PCB77 were 
chosen to be exposed together with LPS and Pam3CSK4. The environmental toxicant had no 
significant effect on Tnf-α formation induced by LPS and PAM3CSK4 (Fig. 20-21).  
 
Figure 18 Tnf-α production in whole blood after exposure to 0.01 – 10ng/mL LPS. (n=3) Two-way ANOVA with 
Bonferroni posttest indicated statistical significance between NaCl and LPS. (interaction:***, dose:***, time:***) 
***p<0.001   **p<0.01 and  *p<0.05 (n=3) 
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Figure 19 Tnf-α production in whole blood after exposure to 2 – 1000ng/mL Pam3CSK4. Two-way ANOVA with 
Bonferroni posttest indicated statistical significance between NaCl and Pam3CSK4. (interaction:***, dose:***, time: 
***) ***p<0.001   **p<0.01 and  *p<0.05 (n=3)  
 
Figure 20 Tnf-α production in whole blood after exposure to A1254 and PCB77 at different concentrations with 
1ng/mL LPS. Two-way ANOVA with Bonferroni posttest indicated statistical significance between DMSO+LPS and 
A1254 or PCB77. (A1254: interaction: **, dose: ns, time: *** PCB77: interaction: ns, dose: ns, time:***) ***p<0.001   
**p<0.01 and  *p<0.05 (n=5) 
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Figure 21  Tnf-α production in whole blood after exposure to A1254 and PCB77 at different concentrations with 
100ng/mL PAM3CSK4. Two-way ANOVA with Bonferroni posttest indicated statistical significance between 
DMSO+Pam3CSK4 and A1254 or PCB77. (A1254: interaction: ns, dose: ns, time: *** PCB77: interaction:***, dose:*, 
time:***) ***p<0.001   **p<0.01 and  *p<0.05 (n=5) 
3.2 ROS Production in Granulocytes 
3.2.1 Dose Response with Environmental Toxicants 
Isolated granulocytes were exposed to different concentrations of five environmental 
toxicants to see if they induced ROS production. All the environmental toxicants tested 
showed a dose-response relationship, as pictured in figure 22 and 23, with EC50 values as 
shown in table 4. There was considerable variation in response between the donors, figure 22 
and 23.  
A1254 had a lower induction of ROS than ortho-chlorinated PCB153. Bisphenol A 
surprisingly induced a negative dose-response relationship. Triclosan and HBCD had a 
positive but small dose-response effect on ROS production. 
Table 4 EC50 of raw data. 
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PCB153(µM) 8.431 
PMA (nM) 4.391 
Triclosan (µM) 6.245 
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Figure 22 The dose-response relationship for A1254, Bisphenol A and HBCD. The results from each separate 
experiment are shown to the right and the total result with indications of significance is shown to the left.  One-way 
ANOVA followed by Dunnet’s multiple Comparison test indicated statistically significant differences between 
exposure groups with DMSO as control.  *** p<0.001,   **p<0.01 and  *p<0.05 (n=3-4) 
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Figure 23 The dose-response relationship for PCB153, PMA and Triclosan. The results from each separate 
experiment are shown to the right and the total result with indications of significance is shown to the left.                   
One-way ANOVA followed by Dunnet’s multiple Comparison test indicated statistically significant differences 
between exposure groups with DMSO as control.  *** p<0.001,   **p<0.01 and  *p<0.05 (n=3-4) 
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The ROS production was initiated at different times for the different substances, illustrating 
different kinetics of the ROS formation (Fig. 24). Triclosan was early up and early down, 
while A1254, HBCD, PCB153 and PMA started at approximately the same time but with 
different shapes or potency of the reaction.  
 
Figure 24 Luminescence measurements during 1 hour after exposure. (Pictures shows the graph for the maximum 
concentration of each of the test compounds, except for PMA which is shown at 10nM) 
3.2.2 LPS Priming of Granulocytes 
Human neutrophil granulocytes were primed with 1ng/mL LPS for 2 hours on ice or for 1 
hour at room temperature and were then exposed to five concentrations of PMA, A1254 or 
Triclosan. The priming seemed to suppress the response of the toxicants investigated (Fig.25).  
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Figure 25 The original Dose-Reponse curves from figure 22 and 23 for A1254, PMA and Triclosan together with the 
response from cells primed with 1ng/mL LPS exposed to A1254, PMA and Triclosan. LPS did not give a response 
alone at these concentrations (data not shown). Two-way ANOVA indicated statistical significance between groups, 
see table 5. *** p<0.001,   **p<0.01 and *p<0.05 (n=3) 
Table 5 Statistical significance of treatment with LPS 
 
 
 
 
 A1254 PMA Triclosan 
 Two 
hours 
 One 
hour 
Two 
hours 
 One 
hour 
Two 
hours 
 One 
hour 
Interaction *** ** ** * *** ** 
LPS 
treatment/Dose 
***/*** ***/*** ***/*** ***/*** ***/*** ***/*** 
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3.2.3 Y.enterocolitca with Granulocytes 
To find an approximate concentration where Y.enterocolitica started to affect granulocyte 
ROS production, different amounts of CFU (50-250 000) were investigated (Fig. 26). The 
goal was to decide on a concentration of Y.enterocolitica to use in combination with 
environmental toxicants on neutrophil granulocytes. Y.enterocolitica gave a concentration-
dependent increase in ROS formation. 250 000 CFU Y.enterocolitica were chosen, which 
gave a response of 2.485 ±0.533 multiples of HBSS.  
 
Figure 26  The granulocytes were exposed to 50-250 000 CFU Y.enterocolitica.  One-way ANOVA followed by 
Dunnet’s multiple Comparison test indicated statistically significant differences between exposure groups with HBSS 
as control.  *** p<0.001,   **p<0.01 and  *p<0.05 (n=4) 
Since HBSS contains glucose it was likely that Y.enterocolitica replicated before and during 
the experiments. Growth depends on a number of factors, such as temperature, medium and 
nourishment. The growth of Y.enterocolitica in HBSS has not been investigated, but counting 
CFU on agar showed 46.6*10
6
 CFU in the original stock diluted in PBS (t=0); in HBSS the 
stock grew to 66.3*10
6
 CFU in HBSS within 1 hour.  
In the experiments with environmental toxicants mixed with Y.enterocolitica a stock solution 
of approximately 50*10
6
 CFU (54.6*10
6
 CFU) was made with PBS instead of HBSS, to 
inhibit growth. 500µL of this solution was mixed with the cells just before the experiment 
started. The environmental toxicants chosen to investigate mixture effects with 
Y.enterocolitica were A1254, PCB153 and Triclosan. 
As seen in figure 25, co-exposure with Y.enterocolitica did not change the results for A1254. 
It seems that the effect of PCB153 together with Y.enterocolitica was affected more strongly 
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(Fig. 27-28). Triclosan showed a bell-shape curve (Fig. 29), with somewhat reduced effects at 
high concentrations of Triclosan.  
 
Figure 27 The results of A1254+Y.enterocolitica calculated as the result of multiples of DMSO+ Y.enterocolitica and 
transformed with +1.485 ±0.533 to take into account the effect of 250 000 CFU Y.enterocolitica alone. Two-way 
ANOVA showed no significant differences after treatment with Y.enterocolitica. (interaction: ns, dose: ***, 
Y.enterocolitica: ns) *** p<0.001,   **p<0.01 and  *p<0.05 (n=3) 
 
Figure 28 The results of PCB153+Y.enterocolitica calculated as the result of multiples of DMSO+Y.enterocolitica and 
transformed with +1.485 ±0.533 to take into account the effect of 250 000 CFU Y.enterocolitica alone. Two-way 
ANOVA showed significant differences after treatment with Y.enterocolitica. (interaction: *, dose: ***, 
Y.enterocolitica: ***) *** p<0.001,   **p<0.01 and  *p<0.05 (n=3)   
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Figure 29 The results of Triclosan+Y.enterocolitica calculated as the result of multiples of DMSO+ Y.enterocolitica and 
transformed with +1.485 ±0.533 to take into account the effect of 250 000 CFU Y.enterocolitica alone. Two-way 
ANOVA showed significant differences after treatment with Y.enterocolitica. (interaction: ***, dose: **, 
Y.enterocolitica: ns) *** p<0.001,   **p<0.01 and  *p<0.05 (n=3)   
3.2.4 Mixture Effects of Environmental Toxicants. 
Binary mixtures of toxicants were made (table 5). Bisphenol A, Triclosan and HBCD were 
mixed with A1254, PCB153 and PMA.  The mix was made in a ratio according to their EC50 
values (table 4 and 6). Then neutrophil granulocytes were exposed to five or six different 
concentrations of these mixtures.  
Table 6 The ratio between the                                                                                                                                    
constituents of the mixtures. 
The binary mixtures induced an apparent dose-dependent increase 
in ROS formation, with the exception of three mixtures with 
Triclosan (Fig. 30). Due to large individual variations in ROS 
response, only Triclosan mixed with A1254 and Triclosan mixed 
with HBCD had reactions significantly different from the control. 
Three of the mixtures with Triclosan seemed to have a reduced 
formation of ROS at higher concentrations. 
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Mixtures  Ratio 
Triclosan/A1254 1.2 
Triclosan/PCB153 1.4 
Triclosan/PMA 1427 
HBCD/Triclosan 2.5 
Bisphenol A/A1254 5.2 
Bisphenol A/PCB153 5.6 
Bisphenol A/PMA 343 
HBCD/A1254 2 
HBCD/PCB153 3.8 
43 
 
 
Figure 30  Binary mixture effects. Information in parantheses states whether to multiply (*) or divide (/) by X to learn 
the concentration of the other constituent of the mixture. Only Triclosan+A1254 and Triclosan+HBCD have a result 
significantly higher than the controls. One-way ANOVA followed by Dunnet’s multiple Comparison test indicated 
statistical significant differences between exposure groups with DMSO as control.  *p<0.05 (n=4) 
It is interesting to note how the kinetics, as observed with AUC, changed for the mixtures 
(Fig. 31 and 32) compared to the kinetics of the single toxicants (Fig. 24). The kinetics even 
varied at different concentrations of the binary mixture of Triclosan and PMA (bottom of Fig 
32).  The mixtures with HBCD or Bisphenol A displayed kinetics similar to a combination of 
the kinetics of the single constituents (Fig. 31-32). 
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To compare the observed ROS-formation of the mixtures with the values predicted by the 
Loewe or the Bliss model, each of the values were presented in a graph. All results were 
transformed as described in sections 2.3.2 - 2.3.4. Normally an isobol diagram would have 
been designed to investigate if a mixture was additive or not (appendix I.v). This was not 
possible with these mixtures because of the variation between donors and the shape of the 
dose response curves. Graph Pad Prism was used to perform multiple regression analysis. The 
results were given in the two-way ANOVA format. If a prediction holds, there should be no 
significant difference between the curve of the observed values and the curve of the predicted 
values. 
Mixtures with Triclosan 
Mixtures with Triclosan and A1254, PCB153 and PMA did not follow predictions closely  
with a predominant antagonistic trend (Fig. 33, 35-36). The binary mixture with HBCD and 
Triclosan reacted differently than the other mixtures with Triclosan (Fig.34). Here, the mean 
ROS production was above the predicted values, but the differences were not significant due 
to the large variation between donors.  
 
Figure 32 AUC for Bisphenol A mixtures at the 
maximum concentration used for each of the 
compounds(top) and Triclosan mixtures (middle and 
bottom) with concentrations shown for mixture with 
PMA. PCB153 at 18.1µM and A1254 at 5.5µM and 
55µM 
 
Figure 31 AUC for HBCD mixtures at the maximum 
concentration used for each of the compounds. 
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Figure 33 The experimental value and the predicted values for different concentrations of an EC50 ratio mixture of 
A1254 and Triclosan. Loewe Prediction vs. Observed Value: **p<0.01 
 
Figure 34 The experimental value and the predicted values for different concentrations of an EC50 ratio mixture of 
HBCD and Triclosan. No significant differences. 
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Figure 35 The experimental value and the predicted values for different concentrations of an EC50 ratio mixture of 
PCB153 and Triclosan. Loewe Prediction vs. Observed Value: ***p<0.001    
 
Figure 36 The experimental value and the predicted values for different concentrations of an EC50 ratio mixture of 
PMA and Triclosan. Loewe Prediction vs. Observed Value:*p<0.05 
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Mixtures with HBCD 
The binary mixtures with HBCD and PCBs seemed to follow closely the Loewe prediction at 
most concentrations, whereas Bliss predicted higher effects than observed. Note, however, 
that the observed effects were not significantly different from the Bliss predictions (Fig. 37-
38). In the mixture with PCB153 there was a trend toward antagonistic effects at higher 
concentrations compared to the predictions. 
 
Figure 37 The experimental value and the predicted values for different concentrations of an EC50 ratio mixture of 
A1254 and HBCD. No significant differences. 
 
Figure 38 The experimental value and the predicted values for different concentrations of an EC50 ratio mixture of 
PCB153 and HBCD. No significant differences. 
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Mixtures with Bisphenol A 
All the binary mixtures with Bisphenol A showed a suppressed response compared to the 
predictions by independent action (Fig.39-41).  
 
Figure 39 The experimental value and the predicted Bliss value for different concentrations of an EC50 ratio mixture 
of A1254 and Bisphenol A. Bliss Prediction vs. Observed Value: ***p<0.001    
 
Figure 40 The experimental value and the predicted Bliss value for different concentrations of an EC50 ratio mixture 
of PCB153 and Bisphenol A. Bliss Prediction vs. Observed Value: ***p<0.001    
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Figure 41 The experimental value and the predicted Bliss value for different concentrations of an EC50 ratio mixture 
of PMA and Bisphenol A. Bliss Prediction vs. Observed Value: ***p<0.001    
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4 Discussion 
4.1 Whole Blood 
4.1.1 Developing a Whole Blood Model for Y.enterocolitica 
A model which investigates immune responses to different bacteria in whole blood is 
currently under development at FFI. Y.enterocolitica was chosen as a test bacterium because 
it has LPS similar to other gram-negative bacteria (Mandel et al., 2005). As seen in figure 13, 
increased concentrations of bacteria caused an increase in Tnf-α production. This made 
Y.enterocolitica a promising test candidate for the characterization of bacteria with the whole 
blood model. 
One interesting observation was that the BHI medium, in which the bacteria were grown, 
induced cytokine production in blood (data not shown). This may be due to the growth factors 
present in the medium. BHI was replaced by PBS, a saline phosphate buffer, which had no 
effect on cytokine production. Another useful observation was that the amount of PBS did not 
seem to affect the amount of Tnf-α pr. CFU at the concentrations tested. During experiments 
the ratio between whole blood and PBS can be changed accordingly, so that less whole blood 
is necessary for each experiment. 
There was a great variability between different donors in how well Y.enterocolitica survived 
in the blood. In addition, the predicted concentration of CFU did not match the counted CFU 
after the experiments. Therefore, the amount of Y.enterocolitica differed between each 
experiment. This made it challenging to reproduce experiments with this bacterium. Some of 
these differences could be explained by the processing of the cells with washing and 
disssolving in PBS, which may reduce the amount and the viability of the cells.  
 
A solution for the variability between whole blood donors may be cryopreservation of blood. 
This would make it possible to get enough blood for several experiments from a homogenous 
mixture of donors. The problem with this solution is that treatment such as cryopreservation 
of blood may affect the results, for example by altering cytokine production (Chen et al., 
2010). A solution to the inconsistent of amounts of bacteria present might be to make a 
culture of Y.enterocolitica, wash and dissolve the culture in PBS, make dilutions of the PBS-
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solution to determine CFU, and kill the bacteria right after the dilutions are made. If the 
bacteria can be killed without destroying the membrane, the result should not strongly affect 
the immune response to the bacteria in whole blood. This culture can then be stored for use in 
several experiments. Another option would be to introduce a bacteria-static chemical. They do 
not kill bacteria, but they inhibit cell division and other processes in the bacteria. 
4.1.2 Whole Blood Model with Environmental Toxicants 
Environmental toxicants were screened at high concentrations, and all of the toxicants tested 
showed a low but significant induction of Tnf-α in some of the donors. Based on the 
screening experiment, PCB77, A1254 and HBCD were selected to evaluate dose-response 
relationships. In this experiment there was no significant formation of IL-1β. Even though 
there was significant production of Tnf-α at different doses of toxicants, there was no 
apparent relationship between dose and response. This can be explained by large individual 
variations in response to the toxicants. Errors in experimental setup, such as contamination 
with bacteria in the blood were also options. In principle, healthy subjects were chosen, but 
some may have had an infection, causing a high background cytokine level (Fig. 20-21). This 
might have hidden responses that were there. 
PCB77 has previously been shown to induce Tnf-α production in vitro with doses as low as 
3.4µM for 16h, but this was performed with HOVEC, which is human umbilical vascular 
endothelial cells (Wang et al., 2010). The difference in cell type or the fact that whole blood 
was used might explain the result. Whole blood contains proteins, ions and other chemicals 
that might interact with PCB77, making it less potent.  
A1254 and PCB77 were then mixed with low concentrations of the bacterial analogs LPS and 
Pam3CSK4, 1ng/mL and 100ng/mL respectively. This was done to investigate modulations in 
the expected immune response to the bacterial analogs by the environmental toxicants. No 
modulations were observed. The lack of effect does not exclude the possibility that they have 
an immunomodulating effect on cytokine production.  
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4.2 Granulocytes’ ROS Production 
4.2.1 ROS Production after Exposure to Environmental Toxicants 
The activation of respiratory burst and inhibition of phagocytosis are established biomarkers 
for immunotoxcitity in wildlife species (Zelikoff et al., 2000). ROS production by neutrophil 
granulocytes might affect cellular homeostasis by cellular signaling or gene regulation 
(Finkel, 1998; Allen and Tresini, 2000). Inappropriate activation of the NADPH oxidase 
system is associated with tissue injury and impaired ability to clear invading microorganisms 
(Labro, 2000). It is therefore interesting to know if environmental toxicants cause ROS 
formation in human neutrophil granulocytes. 
With exception of Bisphenol A there seemed to be concentration-dependent ROS-production 
for all toxicants tested on granulocytes. PMA, which is a well-known ROS inducer in 
granulocytes, was used as a positive control and showed a concentration-dependent increase 
in ROS-formation (Fig. 23).  
Bisphenol A appeared to induce a concentration-dependent reduction of the basal ROS 
formation as measured with DMSO (Fig. 22). This was in contrast to the results by Reistad et 
al. (2005) which showed, depending on the probe used, either a small increase in ROS 
production as a result of BPA exposure, or no effect at all. In their study, Reistad et al. used 
the DCFH-DA-fluorescence assay to measure ROS, which primarily detects intracellular 
ROS, such as H2O2, OH
-•
, 
•
NO and ONOO
-
 (Freitas et al., 2009). Reistad et al. also used a 
lucigenin chemiluminescence assay, which gave no increase in ROS. Lucigenin detects 
extracellular  O2
-•
. The difference in results might be explained by the use of different probes 
or the localization of ROS formation in the cell. Luminol detects both intracellular and 
extracellular ROS, primarily HOCl (Myhre et al., 2003).  
HBCD seemed to induce a small concentration-dependent increase in ROS production, with 
results significantly different from DMSO at 20µM and 50µM (Fig. 22) HBCD has 
previously been shown to induce oxidative stress in zebrafish embryos (Deng et al., 2009), 
but not in cell preparations, such as cerebellar granule cells, as measured with DCHF-DA 
(Reistad et al., 2006). 
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Both A1254 and PCB153 induced a concentration dependent increase in ROS production with 
results significantly different from DMSO at 5µM (Fig. 22-23). The maximum response of 
PCB153 was higher than the maximum response for A1254. Previously, Voie et al. (2000) 
showed that induction of respiratory burst in granulocytes was structure dependent. They 
found that a moderate size, ortho-substitution and a specific 2,4,6-substitution on one ring 
may produce optimal activity. Aroclor 1254 is dominated by di-ortho-chlorinated PCB 
congeners with an average of five substituted chlorines (Bedard and May, 1996). Reistad et 
al. (2005) also found ROS formation at 10µM PCB153 in human granulocytes with the 
lucigenin chemiluminescence assay, but no effect with DCFH-DA assay. This may indicate 
that only extracellular ROS were produced, or that O2
•-
and HOCl were the only ROS formed, 
which according to Freitas et al. (2009) are not detected by DCFH-DA. 
Triclosan induced a small concentration-dependent increase in ROS-production with results 
significantly different from DMSO, for all concentrations tested (Fig. 23). It reacted 
differently from the other environmental toxicants, with a small ROS-production induced 
early in the measurements. Triclosan has previously been shown to induce oxidative stress in 
the earthworm Eisenia fetida (Lin et al., 2010). 
Viability has not been investigated in this study. If the environmental toxicants caused cell 
death during the assay, this could cause less ROS production than expected. If for example 
A1254 is more cytotoxic than PCB153, this might explain the higher effect of PCB153 on 
ROS formation. 
Reistad et al. (2005) investigated lactate dehydrogenase leakage, which is an indication of cell 
death, after exposure to Bisphenol A at 20µM in 5 minutes and 12 µM in 30 minutes without 
observing reduced viability. PCB153 was also investigated this way at 5µM with similar 
result (Reistad and Mariussen, 2005).  
4.2.2 LPS, Y.enterocolitica and Environmental Toxicants. 
Two approaches to investigate immunomodulating effects on an actual pathogen invasion 
were tested on human neutrophil granulocytes: LPS priming and bacterial invasion by 
Y.enterocolitica. LPS priming simulates a bacteria exposure where LPS is released from the 
infected site into the blood. Neutrophils have some TLRs so their ROS-production might be 
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affected by LPS. They are, in addition, known phagocytes so they were expected to produce 
ROS after exposure to Y.enterocolitica. 
LPS priming of human neutrophil granulocytes seemed to cause a suppression of the ROS-
formation normally induced by A1254, PAM and Triclosan (Fig. 25). LPS alone did not cause 
any ROS production at the concentration used for priming the cells (data not shown). LPS 
does not kill host cells or inhibit cellular functions. It starts a cascade of events which can lead 
to systemic shock and death of the host (Galanos and Freudenberg, 1993). A suppression of 
ROS-production could also be caused by degeneration of the cells due to incubation 
temperature or the time consumed by the priming process.  
Y.enterocolitica seemed to affect ROS production in a concentration-dependent manner. The 
effect was significant when the ratio between neutrophile granulocytes and bacteria was 
approximately 1:1 (Fig. 26). This ratio together with increasing concentrations of A1254 gave 
no significant results on ROS production compared to the same concentrations of A1254 
alone (Fig. 27). The same was true for the positive control with PMA (10nM) (data not 
shown). With PCB153, however, induction of ROS in human neutrophil granulocytes seemed 
to be suppressed by the presence of Y.enterocolitica (Fig. 28-29). The reason for the 
difference in response between the two PCB mixtures is not obvious and deserves a more 
thorough investigation. It may be due to influence on cell viability and congener-specific 
effects. 
As for PCB153, Triclosan’s induction of ROS in human neutrophil granulocytes also seemed 
to be suppressed by the presence of Y.enterocolitica (Fig.29). Here a two-way ANOVA 
indicated that the interaction between Y.enterocolitica and the dose of Triclosan varied 
significantly. Figure 29 illustrates that a higher dose of Triclosan had a different effect to the 
treatment than a low dose. The antimicrobial activity of Triclosan (Fang et al., 2010), might 
explain the reduced ROS production. At low concentrations Triclosan inhibits the lipid 
production, and at high concentrations it will disrupt the membrane of the bacteria, without 
perforating the membrane (Villalain et al., 2001)(see section 1.3.4). Depending on the 
morphology of dead bacteria, phagocytosis of Y.enterocolitica might still occur and induce 
ROS formation. The lower response to Triclosan at higher concentrations can be due to 
inactivation of some of the Triclosan due to the antimicrobial activity, or it could indicate a 
shift in response towards fighting an infection. 
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The effect of toxicants in combination with bacteria could not be predicted with the Loewe or 
the Bliss model. The dose-response curve of Y.enterocolitica lacked a maximum effect 
(Fig.26) which is necessary to create an asymetrical Hill-shape curve (section 2.3.2). With use 
of the simple effect summation, which is only valid for chemicals with a linear dose response 
relationship (Berenbaum, 1989), the results indicated that the bacteria had versatile effects on 
toxicants. Depending on where the effects are on the dose-response curve, the effects could 
have been over- or underestimated with this approach.  
4.2.3 Mixture Effects in Granulocytes 
Binary mixtures were made between Triclosan, HBCD and Bisphenol A and PMA and PCBs. 
It was difficult to decide if concentration addition or independent action would apply, because 
the mechanism of effect for some of the chemicals was unknown. Therefore, two models, 
Loewe concentration addition and Bliss independent action, were used to predict mixture 
effects.  PMA and PCBs have known mechanisms of effects; if either the Loewe or the Bliss 
predictions were applicable this could give an indication of the mechanism of Triclosan, 
HBCD or Bisphenol A. 
Triclosan seemed to follow neither Bliss nor Loewe at high concentrations in binary mixtures 
(Fig. 33-36). At high concentrations of mixtures with A1254, PMA and PCB153 the effect 
was antagonistic. Mixtures with PMA seemed to follow the Bliss prediction or even be 
synergistic at low concentrations.  
In the binary mixture with HBCD and Triclosan there was a tendency towards more than an 
additive effect or at least more independent action than concentration addition. This was, 
however, not significant due to variation between donors (Fig. 34). HBCD in mixture with 
either A1254 or PCB153 seemed to follow the Loewe model of additivity (Fig. 37-38) and 
this might indicate that HBCD works by mechanisms similar to ortho-chlorinated PCBs.  
Bisphenol A clearly reacts in a different manner than PMA, A1254 and PCB153. Therefore 
independent action was the only model used for predictions of binary mixtures with 
Bisphenol A. The mixtures were antagonistic compared to the model, especially the mixture 
with PMA (Fig. 41). The antagonistic effect might be caused by underestimation of Bisphenol 
A’s slope because of the experimental set-up. The slope of Bisphenol A seemed to reach a 
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plateau at 5µM (Fig. 22) and this might indicate that it had supressed all ROS formation at 
that concentration.  
In Binary mixtures with Bisphenol A and either A1254 or PCB153, Bisphenol A seemed to 
supress most of the ROS the PCBs produced. Bisphenol A mixed with PCBs had no negative 
slope as it had alone, but it seemed to suppress the response of PCBs (Fig. 30). With PMA, on 
the other hand, the slope went further down (not significantly) before it started to rise again 
(Fig. 30), indicating another kind of effect. 
As seen in figure 31 and 32 the AUC, which indicates the kinetics of ROS production, 
changed shape for some of the mixtures compared to the individual AUC shape for the 
compounds. At lower concentrations of the mixtures with Triclosan and PCBs, the mixture 
seemed to follow the kinetics of the PCBs. At higher concentrations of triclosan mixed with 
PCB153 the mixture followed the kinetics of PCB153 but with suppressed effects at higher 
concentrations (Fig. 32). This is different from the PCB mixture with A1254. Here the 
triclosan kinetics seemed to control the reaction-kinetics at the highest concentration (Fig. 
32).  
At the lowest concentration of PMA and Triclosan, PMA’s kinetics seemed to control the 
reaction. At higher concentrations of the mixture the reaction started early and lasted for some 
time, this seemed to be a combination of the reaction-kinetics of Triclosan and PMA. At the 
highest concentration of the mixture Triclosan seemed to control the kinetics (Fig. 32). 
HBCD and Bisphenol A mixtures appeared to follow the same kinetics as the single 
compounds. Bisphenol A lowered the general response of A1254, PCB153 and PMA. HBCD 
gave the same responses, other than with Triclosan, which had kinetics that seemed to be a 
combination of the compounds of the binary mixture (Fig. 31). It seemed that the ROS 
formation was induced by several mechanisms, where one mechanism either dominated the 
ROS production or stopped the other mechanisms from inducing ROS. This phenomenon 
remains to be elucidated. 
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5 Future Work and Conclusion 
5.1 Future Work 
5.1.1 Whole Blood 
The whole blood model is intended to be used on unknown pathogens in order to develop a 
database with a characterization of known bacteria’s cytokine production. The theory is that 
this database can be used on unknown pathogens to compare cytokine response with known 
pathogens, which might indicate a similar degree of pathogenicity in vivo. This is uncharted 
territory and requires much further work.  
With Y.enterocolitica several other cytokines, and maybe also interferons, need to be 
characterized; this is necessary to get enough markers for comparison. It is also necessary to 
investigate the incubation time of the model. One reason for this is that different cytokines 
have peaks at different times during the incubation period (Wang et al., 2000). 
Cryopreservation of blood should also be investigated. Bacteria instigate high cytokine 
production so the benefit of a similar blood population might be more important than some 
suppressed effects.  
It is of interest to know if environmental toxicants affect a healthy person the same way they 
affect a sick person. In our study, it seems that the effect of environmental toxicants on 
monocytes cytokine production in whole blood is minimal. An inflammatory situation was 
also investigated, but PCB77 and A1254 with the bacterial analogs did not show any 
immunomodulating effects. Since I found nothing conclusive, this should be investigated 
further. It has previously been postulated that there is a link between the concentration of 
environmental pollutants, like PCBs, and mortality caused by different viruses in sea 
mammals such as seals and dolphins (Aguilar and Borrell, 1994; Olsson et al., 1994). Also, 
Triclosan has been shown to reduce the amount of inflammatory cytokines in inflammation 
caused by LPS in whole blood (Barros et al., 2010). This might be the case for other 
environmental toxicants such as Bisphenol A and TPPBA. 
It would also be interesting to see if Triclosan affects Tnf-α production induced by 
Y.enterocolitica the same way it does LPS. To be able to compare results, a dose-response 
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curve for Y.enterocolitica should be developed. Then a concentration in the middle of the 
linear range could be used, to make sure that Triclosan can affect Tnf-α production in either 
direction.  
5.1.2 Granulocytes 
Environmental toxicants and bacteria affect ROS production in human neutrophil 
granulocytes. The effect of Bisphenol A, Triclosan and HBCD on ROS production should be 
investigated further. In other studies, Bisphenol A has caused a slight elevation in ROS 
response (Reistad et al., 2005) and it would be interesting to know if this has something to do 
with where the ROS are produced. Also, how the effect takes place should be investigated. In 
an investigation of a polymerization process with Bisphenol A, Kodoma and Fujisawa (2000) 
suggested that Bisphenol A scavenged radicals, this could explain why the basal DMSO level 
of ROS is supressed by Bisphenol A. Triclosan gives an early response in ROS production 
and the mechanisms involved should be investigated. The mode of action of HBCD should 
also be investigated as it might have similar mechanisms to ortho-chlorinated PCBs. The 
viability of the cells after exposure to the environmental toxicants should also be investigated. 
LPS seems to reduce the effect exhibited by environmental toxicants. This should be 
investigated further to check if the cells’ viability is affected by the priming with LPS. It is 
also interesting to see if these results will be the same with other environmental toxicants. 
This could indicate that TLR activation causes a shift in the priority of the cells away from 
ROS production, towards cytokine production or other responses. 
Y.enterocolitica seemed to affect the effect of the ortho-chlorinated PCB153 more than 
A1254, indicating congener-specific effects, even though A1254 primarily contain ortho-
chlorinated PCB congeners. The first step would be to investigate the viability of human 
neutrophil granulocytes after PCB exposure. This could indicate whether PCB153 is more 
cytotoxic than A1254. Also, a dose-response curve with Y.enterocolitica should be developed 
so concentration addition can be used on mixtures with Y.enterocolitica and ortho-chlorinated 
PCBs, because they both activate the NADPH oxidase system.  
There was a large variation in ROS-response between donors, making it challenging to 
establish certain results, especially in the mixture experiments. Use of granulocytes from male 
donors may reduce the variation in response. Of practical reasons, blood was in our study. 
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sampled from female volunteers and not from male as previously performed at our institute 
(e.g. Reistad et al., Myhre et al., Voie et al.). It has been claimed that male blood is less 
influenced by hormonal changes, which may influence experiments. Whether gender is a 
factor that may influence ROS production in granulocytes remains, however, to be elucidated. 
Mixtures of environmental toxicants are important to investigate. If the constituents of a 
mixture are additive or synergistic when mixed together, this could affect the risk 
management of these compounds. Mixtures with more constituents, similar to what we might 
be exposed to in different scenarios, should be investigated further. The binary mixtures 
studied were mainly antagonistic at higher concentrations. The kinetics observed could 
indicate that the concentration of the mixture decides if one or both of the constituents are 
involved in ROS formation. This could mean that a cell is not able to use two pathways for 
ROS production at maximum capacity at the same time, or that if one pathway is activated the 
other one is blocked. This should be investigated further.   
The models predicted most of the effects of the binary mixtures poorly. The effects observed 
were often lower than the predicted effects, so from risk assessment perspectives this was not 
a problem. The luminol chemiluminescence assay on human neutrophil granulocytes may not 
be the perfect method for investigations of mixture effects. The luminol detects several ROS, 
and we do not know what ROS the constituents of the mixtures induced production of.  The 
prediction models might work better on a lucigenin chemiluminescence assay because it only 
detects O2
-• 
(Freitas et al., 2009). The total ROS production could be more relevant when 
extrapolating results from in vitro to in vivo. On the other hand, the cells were isolated, so it is 
not possible to conclude anything about actual effects in blood. As seen with the whole blood 
model, toxicants may become less potent in blood, where there are numerous constituents 
they could interact with. 
The mixtures with HBCD and PCBs or Triclosan followed the predictions better than any of 
the other mixtures. HBCD and PCBs followed the Loewe model, while HBCD and Triclosan 
followed the Bliss model closely. It would be interesting to investigate the effects of the 
single constituents, with a focus on whether there are any similarities in the pathways leading 
to ROS formation.  
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5.2 Conclusion 
In this thesis mixture effects between different toxicants, bacteria and bacterial analogs have 
been investigated on cytokine production in whole blood and ROS production in human 
neutrophil granulocytes. 
When characterizing Y.enterocolitica with the whole blood model, I found a concentration-
dependent increase in production of Tnf-α in whole blood. To reduce background production 
of Tnf-α in whole blood the bacteria should be dissolved in PBS not medium. The amount of 
PBS does not affect the relative production of Tnf-α. The whole blood model had too much 
variation between different donors to elucidate the induction of cytokine production by 
environmental toxicants. The results from these experiments were inconclusive. 
The environmental toxicants showed potential to induce ROS in human neutrophil 
granulocytes. Compared to what is expected to find in blood (Thomsen et al., 2002; Knutsen 
et al., 2008; Kvalem et al., 2009), the concentrations used in these experiments were high. 
Because of this and because of the complex mechanisms involved in ROS formation it is 
difficult to extrapolate to in vivo reactions. There are, however, scenarios with lipid soluble 
contaminants, where animals may be exposed to extremely high concentrations of pollutants 
similar to what was used in this survey. The highest level of PCBs in brain is found in dead 
Polar sea gulls from Svalbard and ranged from approximately 3-90 µmol/kg (Gabrielsen et 
al., 1995). Another probable scenario is mixtures with similarly acting toxicants, here the total 
concentration may be comparable to the concentrations used in this survey (Rajapakse et al., 
2001). Also, even though the concentration found in humans are low, they might affect 
humans or animals when they are vulnerable, such as during development or infections. And 
if starvation occurs, rapid mobilization of fat might cause a sudden increase in the toxicants’ 
concentration in the blood (Klaassen and Watkins, 2003a). 
Bacteria also affected ROS production in human neutrophil granulocytes. Therefore this was 
an endpoint where investigation of mixture effects between toxicants and pathogens was 
possible. LPS seemed to lower the response normally caused by the toxicants tested and also 
the response to PMA by the NADPH oxidase system. Y.enterocolitica seemed to have a 
versatile effect on the effect of different toxicants. The bacteria did not suppress the effect by 
A1254, as it did with PCB153 and Triclosan. This indicates that there might be differences in 
the reactions towards environmental toxicants depending on the state of the immune system. 
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A probable scenario is that the reactions of the body depend on the capability and priorities of 
the cells involved. The effect of environmental toxicants will vary accordingly.  
The Loewe– and the Bliss models predicted the mixture effects poorly. The binary mixtures 
were mostly antagonistic compared to both models; exceptions were mixtures with HBCD. 
This could indicate that the mechanisms of action of the chemicals are too complex to predict 
the results with these models (Traas and Leeuwen, 2007). If one wants to predict mixture 
effects of environmental toxicants on the immune system, another method, like cell death 
assays, might be simpler and follow the models more closely. It would be interesting to know 
at what level of complexity the models still hold. If the models are to be used for risk 
assessment purposes, the level of complexity might indicate how well the results can be 
extrapolated to in vivo. 
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Appendix 
I. Methods 
i. Environmental Toxicants and Bacterial Analogs tested 
on Whole Blood. 
Table 7 Concentrations tested on whole blood.  
 
 
 
 
 
* were also mixed with 1ng/mL LPS and 100ng/mL PAM3CSK4. 
ii. Recipe for Assay Buffer A and Stop Solution  
Table 8 Recipe for Assay Buffer A 
Chemical Amount 
NaCl 8.0g 
Na2HPO4 1.13g 
KH2PO4 0.2g 
KCl 0.2g 
Distilled H2O 1l 
 
Stop Solution:  
2N H2SO4 =1M H2SO4 
95-97% (w/w) H2SO4  
Mw=98,08 g/mol Specific gravity= 1,84 kg/L 
Molar concentration = (1,84x10
3 
g reagent/L)  x (96g H2SO4 /100 g reagent) x (1 mol H2SO4 / 
98,08 g H2SO4 ) = 18,0 mol/L 
Chemical Concentrations tested Diluent 
A1254* 5, 10, 20, 50µM DMSO 
A1242 50µM DMSO 
Bisphenol A 50µM DMSO 
HBCD 5, 10, 20, 50µM DMSO 
PCB 153 50µM DMSO 
PCB 77* 0.1, 1, 5, 10 µM DMSO 
TBBPA 50µM Metanol 
Triclosan 50µM DMSO 
LPS 0.01, 0.05, 0.1, 0.5, 1, 1.5, 5, 10ng/mL 0.9%NaCl 
Pam3CSK4 2, 10, 50, 100, 1000ng/mL 0.9%NaCl 
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To make 100 mL 1 mol/L H2SO4 we need: 1 mol/L x 0,1 L = 0,1 mol 
Volum av 96% w/w H2SO4: 0,1 mol/ 18 mol/L = 0,00550L = 5,5 mL  
5,5 mL 96% H2SO4 diluted to 100 mL with dH2O. 
iii. Environmental Toxicants tested on Granulocytes 
Table 9 Concentrations used in dose-response experiments.  
Chemical Concentrations tested 
A 1254
*+
 1, 5, 10, 20, 50µM 
 Bisphenol A 1, 5, 10, 20, 50µM 
HBCD 1, 5, 10, 20, 50µM 
PCB 153
+
 1, 5, 10, 20, 50µM 
PMA
*
 1, 2.5, 5, 10, 25nM 
Triclosan
*+
 2, 5, 10, 20, 50µM 
* indicates environmental toxicants mixed with cells primed with the bacterial analog LPS. +indicates 
environmental toxicants mixed with Y.enterocolitica. 
Table 10 Concentrations of single constituents of a mixture. 
Mixtures 1/2 Concentrations 1 Concentrations 2 Ratio* 
Triclosan/A1254 0.9, 4.4, 8.9, 17.7, 44.4 µM 1.1, 5.6, 11.1, 22.1, 55.6 µM   1.2 
Triclosan/PCB153 0.7, 2.7, 5.4, 13.4, 32.4 µM 1.0, 3.6, 7.3, 18.1, 43.7 µM 1.4 
Triclosan/PMA 1.0, 5.0, 10.0, 19.9, 49.6 µM 0.7, 3.5, 7.0, 14.0, 34.8 nM 1427 
Bisphenol A/A1254 0.2, 1.2, 2.8, 5.5, 13.9 µM 1.4, 7.2, 14.4, 28.7, 72.2 µM 5.2 
Bisphenol A/PCB153 0.2, 0.75, 1.5, 3.0, 6.0, 9.0 µM 1.0, 4.2, 8.5, 16.9, 33.6, 50.8 µM 5.6 
Bisphenol A/PMA 1.0, 5.0, 9.9, 19.8, 49.8 µM 2.9, 14.5, 29.0, 57.8, 145.3 nM 343 
HBCD/A1254 0.8, 4.0, 8.0, 16.0, 40.2 µM 0.4, 2.0, 3.9, 7.8, 19.5 µM 2 
HBCD/PCB153 0.8, 4.0, 7.9, 15.8, 39.6  µM 0.2, 1.0, 2.1, 4.1, 10.4 µM 3.8 
HBCD/Triclosan 0.8, 4.2, 8.3, 16.6, 41.8 µM 0.3, 1.6, 3.3, 6.5, 16.4 µM 2.5 
* The ratio is the approximate ratio between the two substances’ concentration in the mixture, calculated as the one with the 
lowest concentration divided by the one with the highest concentration. 
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iv. Recipes for Reagents used on Granulocytes 
Table 11 Recipe for Hanks’ Balanced Salt Solutions (HBSS) (Invitrogen, 2005) 
 
Molar weight 
with water 
gram Solved in Xl H2O mL Final 
concentrat
ion g/L 
  
CaCl*2 H2O 147.02 7.351 0.05 1.258 0.185   
KCl 74.56 18.640 0.1 2.146 0.4   
KH2PO4 136.09 6.805 0.05 0.441 0.06   
MgCl2*6H2O 2HH2O 
H H2O 
203.3 10.165 0.05 0.492 0.1   
MgSO4*7H2O 246.48 12.324 0.05 0.406 0.1   
NaHCO3 84.01 2.100 0.05 8.332 0.35   
Na2HPO4*2H2O 177.99 8.900 0.5 26.968 0.06   
NaCl 58.44 73.050 0.5 54.757 8   
 
H2O 
   
 1
l 
     
v. Isobol Diagram 
This was developed by Loewe and Muischnek (1926) to compare the EC of mixtures with 
predicted ECs. 
In this study the EC50 of either the Bliss - or Loewe model would be an additivity line 
between the concentration of a and b that is expected to cause a 50% effect of the mixture. 
Then an EC50 is calculated based on the observed results of the mixture. The concentration of 
each of the compounds at the EC50 are the coordinates of a point; if the models hold the point 
should be on the additivity line. If it was below the line this would indicate synergy and above 
the line this would indicate antagonism. 
It was not possible to calculate EC50 for the mixtures. One reason was the variation of effect 
between donors, another reason was the bell-shape of some of the dose-response curves. 
Therefore the results are compared by individual points instead. 
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II. Results 
i. Growth Rate of Y.enterocolitica 
 
Figure 42 The relationship between Log(CFU) and Log(OD) should be linear. R=0.975, which gives a good indication 
that the relationship is linear. 
 
To make sure that each experiment had the same amount of bacteria present from the start the 
growth rate of Y. enterocolitica was determined as described in section 2.4.1. This experiment 
was done several times, but with small changes each time. The result from the last 
experiment, shown in figure 40, was used as an approximate estimate for the relationship 
between CFU and OD (described in equation 4). 
Log CFU=0.9111*Log(OD)+8.6042       (4) 
 At every experiment with Y. enterocolitica CFU was counted. 
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ii. Confirmation of Bacteria Species: 
All of the tests came up (Fig. 43) during the PCR. Different amounts of DNA may cause the 
difference in when the slope starts to rise. 
 
Figure 43 Amplification curves. 
The similar meltingpoints indicates that they have the same ratio between C and G 
nucleotides in the PCR-product (Fig. 44), an indication that the PCR products are the same. 
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Figure 44 Melting Peaks 
The final results from the sequencing were identical. After a BLAST nucleotide search and 
ribosome database project the results presented in figure 45 and 46 came up as the closest 
matches. This agrees with the Maldi-TOF experiment presented in table 11. 
 
Figure 45 Blast Results: Y.enterocolitica ATCC9610 is the top result.  
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Figure 46 Ribosome Database Project results: Y.enterocolitica ATCC9610 is the top result.  
The result from MALDI-TOF gave a score value of 2.406, 2.300-3.000, indicates highly 
probable species identification (table 11). The result was Y.enterocolitica (serovar O8) ATCC 
9610. 
Table 12 Results from the Maldi confirmation of bacteria 
Analyte 
Name 
Analyte 
ID 
Organism                        
(best match) 
Score 
Value 
Organism                     
(second best match) 
Score 
Value 
YE 
(+++) 
 Yersnina Enterocolitica 
(serovar O8) ATCC 9610T THL 
e Enterocolitica 
 
2.406 Yersiniae Enterocolitica 2.231 
 
